| 7.6 |
22.7 |
GO:0048681 |
negative regulation of axon regeneration(GO:0048681) negative regulation of neuron projection regeneration(GO:0070571) |
| 7.2 |
21.6 |
GO:2000064 |
regulation of cortisol biosynthetic process(GO:2000064) |
| 7.1 |
21.2 |
GO:0046586 |
regulation of calcium-dependent cell-cell adhesion(GO:0046586) |
| 6.2 |
31.0 |
GO:0044854 |
membrane raft assembly(GO:0001765) plasma membrane raft assembly(GO:0044854) plasma membrane raft organization(GO:0044857) caveola assembly(GO:0070836) membrane assembly(GO:0071709) |
| 4.5 |
18.1 |
GO:0030913 |
paranodal junction assembly(GO:0030913) |
| 3.9 |
11.8 |
GO:0071476 |
response to vitamin B1(GO:0010266) cellular hypotonic response(GO:0071476) |
| 3.3 |
9.9 |
GO:0003308 |
negative regulation of Wnt signaling pathway involved in heart development(GO:0003308) |
| 3.1 |
12.5 |
GO:0043128 |
regulation of 1-phosphatidylinositol 4-kinase activity(GO:0043126) positive regulation of 1-phosphatidylinositol 4-kinase activity(GO:0043128) |
| 3.0 |
8.9 |
GO:0048627 |
myoblast development(GO:0048627) |
| 3.0 |
11.8 |
GO:0006089 |
lactate metabolic process(GO:0006089) |
| 2.7 |
8.2 |
GO:0051170 |
nuclear import(GO:0051170) |
| 2.7 |
10.9 |
GO:0002072 |
optic cup morphogenesis involved in camera-type eye development(GO:0002072) |
| 2.6 |
18.0 |
GO:2000111 |
positive regulation of macrophage apoptotic process(GO:2000111) |
| 2.3 |
67.3 |
GO:0031581 |
hemidesmosome assembly(GO:0031581) |
| 2.3 |
6.8 |
GO:0019858 |
cytosine metabolic process(GO:0019858) |
| 2.2 |
6.6 |
GO:0030205 |
dermatan sulfate metabolic process(GO:0030205) dermatan sulfate biosynthetic process(GO:0030208) |
| 2.2 |
8.7 |
GO:0060649 |
nipple development(GO:0060618) mammary gland bud elongation(GO:0060649) nipple morphogenesis(GO:0060658) nipple sheath formation(GO:0060659) |
| 2.1 |
14.8 |
GO:0060346 |
bone trabecula formation(GO:0060346) bone trabecula morphogenesis(GO:0061430) |
| 2.1 |
8.3 |
GO:0046108 |
uridine metabolic process(GO:0046108) |
| 2.0 |
6.1 |
GO:0010273 |
detoxification of copper ion(GO:0010273) stress response to copper ion(GO:1990169) |
| 2.0 |
8.2 |
GO:0031340 |
positive regulation of vesicle fusion(GO:0031340) |
| 2.0 |
6.0 |
GO:0060120 |
auditory receptor cell fate commitment(GO:0009912) inner ear receptor cell fate commitment(GO:0060120) |
| 1.9 |
1.9 |
GO:0072048 |
pattern specification involved in kidney development(GO:0061004) renal system pattern specification(GO:0072048) |
| 1.9 |
9.5 |
GO:0051611 |
negative regulation of neurotransmitter uptake(GO:0051581) negative regulation of dopamine uptake involved in synaptic transmission(GO:0051585) serotonin uptake(GO:0051610) regulation of serotonin uptake(GO:0051611) negative regulation of serotonin uptake(GO:0051612) norepinephrine uptake(GO:0051620) regulation of norepinephrine uptake(GO:0051621) negative regulation of norepinephrine uptake(GO:0051622) negative regulation of catecholamine uptake involved in synaptic transmission(GO:0051945) regulation of thrombin receptor signaling pathway(GO:0070494) negative regulation of thrombin receptor signaling pathway(GO:0070495) |
| 1.7 |
5.2 |
GO:0060547 |
negative regulation of necrotic cell death(GO:0060547) |
| 1.6 |
4.9 |
GO:0043006 |
activation of phospholipase A2 activity by calcium-mediated signaling(GO:0043006) |
| 1.6 |
4.9 |
GO:0002541 |
activation of plasma proteins involved in acute inflammatory response(GO:0002541) |
| 1.6 |
6.4 |
GO:0021506 |
anterior neuropore closure(GO:0021506) neuropore closure(GO:0021995) |
| 1.6 |
6.3 |
GO:0022614 |
membrane to membrane docking(GO:0022614) |
| 1.6 |
1.6 |
GO:1903519 |
apoptotic process involved in mammary gland involution(GO:0060057) positive regulation of apoptotic process involved in mammary gland involution(GO:0060058) positive regulation of apoptotic process involved in morphogenesis(GO:1902339) regulation of mammary gland involution(GO:1903519) positive regulation of mammary gland involution(GO:1903521) positive regulation of apoptotic process involved in development(GO:1904747) |
| 1.5 |
9.3 |
GO:0090025 |
regulation of monocyte chemotaxis(GO:0090025) positive regulation of monocyte chemotaxis(GO:0090026) |
| 1.5 |
4.6 |
GO:0019747 |
regulation of isoprenoid metabolic process(GO:0019747) |
| 1.5 |
1.5 |
GO:0045350 |
interferon-beta biosynthetic process(GO:0045350) regulation of interferon-beta biosynthetic process(GO:0045357) positive regulation of interferon-beta biosynthetic process(GO:0045359) |
| 1.5 |
4.6 |
GO:0046495 |
nicotinamide riboside catabolic process(GO:0006738) nicotinamide riboside metabolic process(GO:0046495) pyridine nucleoside metabolic process(GO:0070637) pyridine nucleoside catabolic process(GO:0070638) |
| 1.5 |
13.8 |
GO:0002553 |
histamine production involved in inflammatory response(GO:0002349) histamine secretion involved in inflammatory response(GO:0002441) histamine secretion by mast cell(GO:0002553) |
| 1.5 |
7.6 |
GO:0006789 |
bilirubin conjugation(GO:0006789) biphenyl metabolic process(GO:0018879) biphenyl catabolic process(GO:0070980) |
| 1.5 |
6.0 |
GO:0046007 |
negative regulation of activated T cell proliferation(GO:0046007) |
| 1.4 |
2.9 |
GO:0046836 |
glycolipid transport(GO:0046836) |
| 1.4 |
4.3 |
GO:0060054 |
positive regulation of epithelial cell proliferation involved in wound healing(GO:0060054) |
| 1.4 |
32.6 |
GO:0045745 |
positive regulation of G-protein coupled receptor protein signaling pathway(GO:0045745) |
| 1.4 |
4.2 |
GO:0006478 |
peptidyl-tyrosine sulfation(GO:0006478) |
| 1.4 |
16.9 |
GO:0010658 |
striated muscle cell apoptotic process(GO:0010658) cardiac muscle cell apoptotic process(GO:0010659) regulation of striated muscle cell apoptotic process(GO:0010662) negative regulation of striated muscle cell apoptotic process(GO:0010664) regulation of cardiac muscle cell apoptotic process(GO:0010665) negative regulation of cardiac muscle cell apoptotic process(GO:0010667) |
| 1.4 |
4.2 |
GO:0010757 |
regulation of plasminogen activation(GO:0010755) negative regulation of plasminogen activation(GO:0010757) |
| 1.4 |
1.4 |
GO:0035025 |
positive regulation of Rho protein signal transduction(GO:0035025) |
| 1.4 |
5.4 |
GO:0032849 |
positive regulation of cellular pH reduction(GO:0032849) |
| 1.3 |
8.1 |
GO:0043312 |
neutrophil activation involved in immune response(GO:0002283) neutrophil degranulation(GO:0043312) |
| 1.3 |
2.7 |
GO:0002693 |
leukocyte migration involved in inflammatory response(GO:0002523) regulation of cellular extravasation(GO:0002691) positive regulation of cellular extravasation(GO:0002693) |
| 1.3 |
7.9 |
GO:2000124 |
cannabinoid signaling pathway(GO:0038171) endocannabinoid signaling pathway(GO:0071926) regulation of endocannabinoid signaling pathway(GO:2000124) |
| 1.3 |
7.9 |
GO:0006295 |
nucleotide-excision repair, DNA incision, 3'-to lesion(GO:0006295) |
| 1.3 |
1.3 |
GO:0031394 |
regulation of prostaglandin biosynthetic process(GO:0031392) positive regulation of prostaglandin biosynthetic process(GO:0031394) regulation of unsaturated fatty acid biosynthetic process(GO:2001279) positive regulation of unsaturated fatty acid biosynthetic process(GO:2001280) |
| 1.3 |
6.4 |
GO:0045743 |
positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
| 1.3 |
2.6 |
GO:0042159 |
lipoprotein catabolic process(GO:0042159) |
| 1.3 |
6.4 |
GO:0050703 |
interleukin-1 alpha secretion(GO:0050703) |
| 1.3 |
5.1 |
GO:0046022 |
regulation of transcription from RNA polymerase II promoter, mitotic(GO:0046021) positive regulation of transcription from RNA polymerase II promoter during mitosis(GO:0046022) |
| 1.3 |
17.8 |
GO:1901797 |
negative regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043518) negative regulation of signal transduction by p53 class mediator(GO:1901797) |
| 1.2 |
4.9 |
GO:0060914 |
heart formation(GO:0060914) |
| 1.2 |
3.7 |
GO:0050965 |
detection of temperature stimulus involved in sensory perception(GO:0050961) detection of temperature stimulus involved in sensory perception of pain(GO:0050965) |
| 1.2 |
4.8 |
GO:0061364 |
response to cortisol(GO:0051414) apoptotic process involved in luteolysis(GO:0061364) |
| 1.2 |
1.2 |
GO:0046110 |
xanthine metabolic process(GO:0046110) |
| 1.2 |
3.6 |
GO:0018243 |
protein O-linked glycosylation via serine(GO:0018242) protein O-linked glycosylation via threonine(GO:0018243) |
| 1.2 |
2.3 |
GO:0070527 |
platelet aggregation(GO:0070527) |
| 1.2 |
2.3 |
GO:0051014 |
actin filament severing(GO:0051014) |
| 1.2 |
16.2 |
GO:0050872 |
white fat cell differentiation(GO:0050872) |
| 1.1 |
6.8 |
GO:0006880 |
intracellular sequestering of iron ion(GO:0006880) sequestering of iron ion(GO:0097577) |
| 1.1 |
6.8 |
GO:0060263 |
regulation of respiratory burst(GO:0060263) |
| 1.1 |
7.9 |
GO:0030579 |
ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
| 1.1 |
3.4 |
GO:0019367 |
fatty acid elongation, saturated fatty acid(GO:0019367) |
| 1.1 |
3.4 |
GO:0045986 |
negative regulation of smooth muscle contraction(GO:0045986) |
| 1.1 |
4.4 |
GO:0042335 |
cuticle development(GO:0042335) |
| 1.1 |
1.1 |
GO:0051898 |
negative regulation of protein kinase B signaling(GO:0051898) |
| 1.1 |
3.3 |
GO:0051503 |
adenine nucleotide transport(GO:0051503) |
| 1.1 |
13.1 |
GO:0008631 |
intrinsic apoptotic signaling pathway in response to oxidative stress(GO:0008631) cell death in response to oxidative stress(GO:0036473) |
| 1.1 |
8.6 |
GO:0046085 |
adenosine metabolic process(GO:0046085) |
| 1.1 |
9.6 |
GO:0010799 |
regulation of peptidyl-threonine phosphorylation(GO:0010799) positive regulation of peptidyl-threonine phosphorylation(GO:0010800) |
| 1.0 |
9.4 |
GO:0060666 |
dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
| 1.0 |
7.3 |
GO:0060438 |
trachea development(GO:0060438) |
| 1.0 |
30.3 |
GO:0007157 |
heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0007157) |
| 1.0 |
3.1 |
GO:0071639 |
positive regulation of monocyte chemotactic protein-1 production(GO:0071639) |
| 1.0 |
7.2 |
GO:0042989 |
sequestering of actin monomers(GO:0042989) |
| 1.0 |
5.1 |
GO:0007386 |
compartment pattern specification(GO:0007386) |
| 1.0 |
6.0 |
GO:0010561 |
negative regulation of glycoprotein biosynthetic process(GO:0010561) |
| 1.0 |
1.0 |
GO:0032465 |
regulation of cytokinesis(GO:0032465) |
| 1.0 |
14.5 |
GO:0051016 |
barbed-end actin filament capping(GO:0051016) |
| 1.0 |
2.9 |
GO:0009648 |
photoperiodism(GO:0009648) |
| 1.0 |
14.3 |
GO:0043616 |
keratinocyte proliferation(GO:0043616) |
| 0.9 |
6.6 |
GO:0030007 |
cellular potassium ion homeostasis(GO:0030007) negative regulation of cell volume(GO:0045794) |
| 0.9 |
0.9 |
GO:0006878 |
cellular copper ion homeostasis(GO:0006878) |
| 0.9 |
2.8 |
GO:0051901 |
positive regulation of mitochondrial depolarization(GO:0051901) positive regulation of membrane depolarization(GO:1904181) |
| 0.9 |
0.9 |
GO:0045603 |
positive regulation of endothelial cell differentiation(GO:0045603) |
| 0.9 |
2.8 |
GO:0032510 |
endosome to lysosome transport via multivesicular body sorting pathway(GO:0032510) |
| 0.9 |
1.8 |
GO:0060525 |
prostate glandular acinus development(GO:0060525) |
| 0.9 |
3.7 |
GO:0000389 |
mRNA 3'-splice site recognition(GO:0000389) |
| 0.9 |
2.7 |
GO:0019371 |
cyclooxygenase pathway(GO:0019371) |
| 0.9 |
5.3 |
GO:0007499 |
ectoderm and mesoderm interaction(GO:0007499) |
| 0.9 |
1.8 |
GO:0036072 |
intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
| 0.9 |
1.8 |
GO:0009143 |
nucleoside triphosphate catabolic process(GO:0009143) |
| 0.9 |
6.2 |
GO:0097384 |
cellular lipid biosynthetic process(GO:0097384) |
| 0.9 |
2.7 |
GO:0006427 |
histidyl-tRNA aminoacylation(GO:0006427) |
| 0.9 |
13.2 |
GO:0043588 |
skin development(GO:0043588) |
| 0.9 |
3.5 |
GO:0043653 |
mitochondrial fragmentation involved in apoptotic process(GO:0043653) |
| 0.9 |
3.5 |
GO:0010591 |
regulation of lamellipodium assembly(GO:0010591) |
| 0.9 |
3.5 |
GO:0060708 |
spongiotrophoblast differentiation(GO:0060708) |
| 0.9 |
0.9 |
GO:0021511 |
spinal cord patterning(GO:0021511) |
| 0.9 |
3.4 |
GO:0046826 |
negative regulation of protein export from nucleus(GO:0046826) |
| 0.9 |
2.6 |
GO:0033278 |
cell proliferation in midbrain(GO:0033278) |
| 0.8 |
0.8 |
GO:0060594 |
mammary gland specification(GO:0060594) |
| 0.8 |
2.5 |
GO:0021819 |
layer formation in cerebral cortex(GO:0021819) |
| 0.8 |
0.8 |
GO:0051590 |
positive regulation of neurotransmitter transport(GO:0051590) |
| 0.8 |
3.3 |
GO:0010815 |
bradykinin catabolic process(GO:0010815) |
| 0.8 |
1.6 |
GO:2000008 |
regulation of protein localization to cell surface(GO:2000008) |
| 0.8 |
0.8 |
GO:0006651 |
diacylglycerol biosynthetic process(GO:0006651) |
| 0.8 |
0.8 |
GO:0001937 |
negative regulation of endothelial cell proliferation(GO:0001937) |
| 0.8 |
3.2 |
GO:0010939 |
regulation of necrotic cell death(GO:0010939) |
| 0.8 |
15.7 |
GO:0031529 |
ruffle organization(GO:0031529) |
| 0.8 |
9.4 |
GO:1904031 |
positive regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045737) positive regulation of cyclin-dependent protein kinase activity(GO:1904031) |
| 0.8 |
2.3 |
GO:0021570 |
rhombomere 4 development(GO:0021570) |
| 0.8 |
2.3 |
GO:0071071 |
regulation of phosphatidylinositol biosynthetic process(GO:0010511) regulation of phospholipid biosynthetic process(GO:0071071) |
| 0.8 |
3.8 |
GO:0046952 |
ketone body catabolic process(GO:0046952) |
| 0.8 |
1.5 |
GO:0043162 |
ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
| 0.8 |
11.4 |
GO:0032456 |
endocytic recycling(GO:0032456) |
| 0.8 |
3.8 |
GO:0021869 |
forebrain ventricular zone progenitor cell division(GO:0021869) |
| 0.7 |
1.5 |
GO:0001973 |
adenosine receptor signaling pathway(GO:0001973) G-protein coupled purinergic receptor signaling pathway(GO:0035588) |
| 0.7 |
2.2 |
GO:0006015 |
5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
| 0.7 |
2.2 |
GO:0006591 |
ornithine metabolic process(GO:0006591) |
| 0.7 |
2.2 |
GO:0010792 |
DNA double-strand break processing involved in repair via single-strand annealing(GO:0010792) double-strand break repair via single-strand annealing(GO:0045002) |
| 0.7 |
5.2 |
GO:0016559 |
peroxisome fission(GO:0016559) |
| 0.7 |
1.5 |
GO:0071679 |
commissural neuron axon guidance(GO:0071679) |
| 0.7 |
2.9 |
GO:0008588 |
release of cytoplasmic sequestered NF-kappaB(GO:0008588) |
| 0.7 |
5.1 |
GO:0043415 |
positive regulation of skeletal muscle tissue regeneration(GO:0043415) regulation of skeletal muscle tissue regeneration(GO:0043416) |
| 0.7 |
3.6 |
GO:0009649 |
entrainment of circadian clock(GO:0009649) |
| 0.7 |
4.3 |
GO:0015803 |
branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
| 0.7 |
2.9 |
GO:0002903 |
negative regulation of B cell apoptotic process(GO:0002903) |
| 0.7 |
2.9 |
GO:1903170 |
negative regulation of ion transmembrane transporter activity(GO:0032413) negative regulation of release of sequestered calcium ion into cytosol(GO:0051280) positive regulation of sequestering of calcium ion(GO:0051284) negative regulation of ryanodine-sensitive calcium-release channel activity(GO:0060315) negative regulation of calcium ion transmembrane transporter activity(GO:1901020) negative regulation of calcium ion transmembrane transport(GO:1903170) negative regulation of cation channel activity(GO:2001258) |
| 0.7 |
2.1 |
GO:0048549 |
positive regulation of pinocytosis(GO:0048549) |
| 0.7 |
4.9 |
GO:0015904 |
tetracycline transport(GO:0015904) |
| 0.7 |
0.7 |
GO:0032330 |
regulation of chondrocyte differentiation(GO:0032330) |
| 0.7 |
2.8 |
GO:0002318 |
myeloid progenitor cell differentiation(GO:0002318) |
| 0.7 |
2.8 |
GO:0051552 |
flavone metabolic process(GO:0051552) |
| 0.7 |
6.1 |
GO:0006474 |
N-terminal protein amino acid acetylation(GO:0006474) |
| 0.7 |
8.8 |
GO:0050716 |
positive regulation of interleukin-1 secretion(GO:0050716) |
| 0.7 |
2.7 |
GO:0015891 |
iron chelate transport(GO:0015688) siderophore transport(GO:0015891) |
| 0.7 |
2.0 |
GO:0070682 |
proteasome regulatory particle assembly(GO:0070682) |
| 0.7 |
2.0 |
GO:1901724 |
positive regulation of cell proliferation involved in kidney development(GO:1901724) |
| 0.7 |
0.7 |
GO:0032060 |
bleb assembly(GO:0032060) |
| 0.7 |
3.3 |
GO:0042415 |
norepinephrine metabolic process(GO:0042415) |
| 0.7 |
4.0 |
GO:0002052 |
positive regulation of neuroblast proliferation(GO:0002052) |
| 0.7 |
1.3 |
GO:0006788 |
heme oxidation(GO:0006788) |
| 0.7 |
2.0 |
GO:0006051 |
mannosamine metabolic process(GO:0006050) N-acetylmannosamine metabolic process(GO:0006051) |
| 0.7 |
2.0 |
GO:0006420 |
arginyl-tRNA aminoacylation(GO:0006420) |
| 0.7 |
2.6 |
GO:0045162 |
clustering of voltage-gated sodium channels(GO:0045162) |
| 0.7 |
13.1 |
GO:0000768 |
syncytium formation by plasma membrane fusion(GO:0000768) |
| 0.6 |
6.5 |
GO:0051085 |
chaperone mediated protein folding requiring cofactor(GO:0051085) |
| 0.6 |
7.1 |
GO:0007216 |
G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
| 0.6 |
0.6 |
GO:0002673 |
regulation of acute inflammatory response(GO:0002673) |
| 0.6 |
0.6 |
GO:0046668 |
retinal cell programmed cell death(GO:0046666) regulation of retinal cell programmed cell death(GO:0046668) |
| 0.6 |
1.9 |
GO:0051231 |
mitotic spindle elongation(GO:0000022) spindle elongation(GO:0051231) |
| 0.6 |
6.3 |
GO:0051927 |
obsolete negative regulation of calcium ion transport via voltage-gated calcium channel activity(GO:0051927) |
| 0.6 |
3.1 |
GO:0006549 |
isoleucine metabolic process(GO:0006549) |
| 0.6 |
2.5 |
GO:0042231 |
interleukin-13 biosynthetic process(GO:0042231) |
| 0.6 |
3.1 |
GO:0017183 |
peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
| 0.6 |
15.4 |
GO:0045103 |
intermediate filament-based process(GO:0045103) |
| 0.6 |
4.2 |
GO:0055091 |
phospholipid homeostasis(GO:0055091) |
| 0.6 |
4.8 |
GO:0031444 |
slow-twitch skeletal muscle fiber contraction(GO:0031444) |
| 0.6 |
1.2 |
GO:0032288 |
myelin assembly(GO:0032288) |
| 0.6 |
1.2 |
GO:0010248 |
establishment or maintenance of transmembrane electrochemical gradient(GO:0010248) |
| 0.6 |
1.2 |
GO:0000380 |
alternative mRNA splicing, via spliceosome(GO:0000380) |
| 0.6 |
0.6 |
GO:0048821 |
erythrocyte development(GO:0048821) myeloid cell development(GO:0061515) |
| 0.6 |
3.6 |
GO:0043001 |
Golgi to plasma membrane protein transport(GO:0043001) |
| 0.6 |
3.0 |
GO:0016199 |
axon midline choice point recognition(GO:0016199) |
| 0.6 |
1.2 |
GO:0006346 |
methylation-dependent chromatin silencing(GO:0006346) |
| 0.6 |
0.6 |
GO:0003321 |
positive regulation of blood pressure by epinephrine-norepinephrine(GO:0003321) |
| 0.6 |
0.6 |
GO:0002679 |
respiratory burst involved in defense response(GO:0002679) |
| 0.6 |
1.2 |
GO:0090598 |
male genitalia morphogenesis(GO:0048808) male anatomical structure morphogenesis(GO:0090598) |
| 0.6 |
4.6 |
GO:0045542 |
positive regulation of cholesterol biosynthetic process(GO:0045542) |
| 0.6 |
2.3 |
GO:0060662 |
tube lumen cavitation(GO:0060605) salivary gland cavitation(GO:0060662) |
| 0.6 |
1.7 |
GO:0031118 |
rRNA pseudouridine synthesis(GO:0031118) |
| 0.6 |
1.7 |
GO:0046521 |
sphingoid catabolic process(GO:0046521) |
| 0.6 |
1.7 |
GO:0050685 |
regulation of mRNA 3'-end processing(GO:0031440) positive regulation of mRNA 3'-end processing(GO:0031442) positive regulation of mRNA processing(GO:0050685) positive regulation of mRNA metabolic process(GO:1903313) |
| 0.6 |
1.1 |
GO:0001300 |
chronological cell aging(GO:0001300) |
| 0.6 |
3.3 |
GO:0071415 |
cellular response to purine-containing compound(GO:0071415) |
| 0.6 |
0.6 |
GO:0051955 |
regulation of amino acid transport(GO:0051955) |
| 0.6 |
0.6 |
GO:0010566 |
regulation of ketone biosynthetic process(GO:0010566) regulation of aldosterone metabolic process(GO:0032344) regulation of aldosterone biosynthetic process(GO:0032347) |
| 0.5 |
3.3 |
GO:2000172 |
cerebral cortex radial glia guided migration(GO:0021801) telencephalon glial cell migration(GO:0022030) regulation of branching morphogenesis of a nerve(GO:2000172) |
| 0.5 |
3.8 |
GO:0045176 |
apical protein localization(GO:0045176) |
| 0.5 |
1.1 |
GO:0009146 |
purine nucleoside triphosphate catabolic process(GO:0009146) purine deoxyribonucleotide catabolic process(GO:0009155) deoxyribonucleoside triphosphate catabolic process(GO:0009204) purine deoxyribonucleoside triphosphate catabolic process(GO:0009217) |
| 0.5 |
0.5 |
GO:0045746 |
regulation of Notch signaling pathway(GO:0008593) negative regulation of Notch signaling pathway(GO:0045746) |
| 0.5 |
2.1 |
GO:0045338 |
farnesyl diphosphate metabolic process(GO:0045338) |
| 0.5 |
1.6 |
GO:0007500 |
mesodermal cell fate determination(GO:0007500) |
| 0.5 |
1.1 |
GO:0043461 |
proton-transporting ATP synthase complex assembly(GO:0043461) proton-transporting two-sector ATPase complex assembly(GO:0070071) proton-transporting ATP synthase complex biogenesis(GO:0070272) |
| 0.5 |
1.1 |
GO:0097709 |
connective tissue replacement involved in inflammatory response wound healing(GO:0002248) connective tissue replacement(GO:0097709) |
| 0.5 |
3.2 |
GO:0046051 |
GTP biosynthetic process(GO:0006183) UTP biosynthetic process(GO:0006228) CTP biosynthetic process(GO:0006241) pyrimidine ribonucleoside triphosphate metabolic process(GO:0009208) pyrimidine ribonucleoside triphosphate biosynthetic process(GO:0009209) CTP metabolic process(GO:0046036) UTP metabolic process(GO:0046051) |
| 0.5 |
2.6 |
GO:0060037 |
pharyngeal system development(GO:0060037) |
| 0.5 |
1.0 |
GO:0060049 |
regulation of protein ADP-ribosylation(GO:0010835) regulation of protein glycosylation(GO:0060049) |
| 0.5 |
3.7 |
GO:0016255 |
attachment of GPI anchor to protein(GO:0016255) |
| 0.5 |
6.8 |
GO:0031053 |
primary miRNA processing(GO:0031053) |
| 0.5 |
2.6 |
GO:0045647 |
negative regulation of erythrocyte differentiation(GO:0045647) |
| 0.5 |
1.0 |
GO:0046931 |
pore complex assembly(GO:0046931) |
| 0.5 |
1.5 |
GO:0035021 |
negative regulation of Rac protein signal transduction(GO:0035021) |
| 0.5 |
0.5 |
GO:0070098 |
chemokine-mediated signaling pathway(GO:0070098) |
| 0.5 |
0.5 |
GO:1900087 |
traversing start control point of mitotic cell cycle(GO:0007089) positive regulation of G1/S transition of mitotic cell cycle(GO:1900087) positive regulation of cell cycle G1/S phase transition(GO:1902808) |
| 0.5 |
1.5 |
GO:0071344 |
diphosphate metabolic process(GO:0071344) |
| 0.5 |
1.5 |
GO:0042268 |
regulation of cytolysis(GO:0042268) |
| 0.5 |
6.1 |
GO:0042474 |
middle ear morphogenesis(GO:0042474) |
| 0.5 |
2.5 |
GO:0002544 |
chronic inflammatory response(GO:0002544) |
| 0.5 |
1.0 |
GO:0060710 |
chorio-allantoic fusion(GO:0060710) |
| 0.5 |
8.0 |
GO:0001945 |
lymph vessel development(GO:0001945) |
| 0.5 |
1.5 |
GO:0046080 |
dUTP metabolic process(GO:0046080) |
| 0.5 |
1.5 |
GO:0034770 |
histone H4-K20 methylation(GO:0034770) |
| 0.5 |
0.5 |
GO:0019883 |
antigen processing and presentation of endogenous antigen(GO:0019883) |
| 0.5 |
0.5 |
GO:0051589 |
negative regulation of neurotransmitter transport(GO:0051589) |
| 0.5 |
0.5 |
GO:0009438 |
methylglyoxal metabolic process(GO:0009438) |
| 0.5 |
1.5 |
GO:0046604 |
regulation of mitotic centrosome separation(GO:0046602) positive regulation of mitotic centrosome separation(GO:0046604) |
| 0.5 |
0.5 |
GO:0051987 |
positive regulation of attachment of spindle microtubules to kinetochore(GO:0051987) |
| 0.5 |
0.5 |
GO:0090205 |
positive regulation of cholesterol metabolic process(GO:0090205) |
| 0.5 |
3.4 |
GO:0055015 |
ventricular cardiac muscle cell development(GO:0055015) |
| 0.5 |
4.4 |
GO:0032331 |
negative regulation of chondrocyte differentiation(GO:0032331) |
| 0.5 |
1.5 |
GO:0071109 |
superior temporal gyrus development(GO:0071109) |
| 0.5 |
14.6 |
GO:0031424 |
keratinization(GO:0031424) |
| 0.5 |
1.9 |
GO:0048295 |
positive regulation of isotype switching to IgE isotypes(GO:0048295) |
| 0.5 |
1.4 |
GO:0060152 |
peroxisome localization(GO:0060151) microtubule-based peroxisome localization(GO:0060152) |
| 0.5 |
1.4 |
GO:0002428 |
antigen processing and presentation of peptide antigen via MHC class Ib(GO:0002428) antigen processing and presentation of exogenous peptide antigen via MHC class Ib(GO:0002477) antigen processing and presentation of exogenous protein antigen via MHC class Ib, TAP-dependent(GO:0002481) |
| 0.5 |
0.5 |
GO:0051057 |
positive regulation of small GTPase mediated signal transduction(GO:0051057) |
| 0.5 |
1.4 |
GO:0032928 |
regulation of superoxide anion generation(GO:0032928) negative regulation of superoxide anion generation(GO:0032929) |
| 0.5 |
15.7 |
GO:0007212 |
dopamine receptor signaling pathway(GO:0007212) |
| 0.5 |
1.9 |
GO:0009642 |
response to light intensity(GO:0009642) |
| 0.5 |
4.7 |
GO:0017121 |
phospholipid scrambling(GO:0017121) |
| 0.5 |
1.9 |
GO:0072393 |
microtubule anchoring at microtubule organizing center(GO:0072393) |
| 0.5 |
5.6 |
GO:0006108 |
malate metabolic process(GO:0006108) |
| 0.5 |
0.5 |
GO:0051547 |
regulation of keratinocyte migration(GO:0051547) positive regulation of keratinocyte migration(GO:0051549) |
| 0.5 |
2.3 |
GO:0006003 |
fructose 2,6-bisphosphate metabolic process(GO:0006003) |
| 0.5 |
2.8 |
GO:0042769 |
DNA damage response, detection of DNA damage(GO:0042769) |
| 0.5 |
3.7 |
GO:0051708 |
intracellular transport of viral protein in host cell(GO:0019060) symbiont intracellular protein transport in host(GO:0030581) regulation by virus of viral protein levels in host cell(GO:0046719) intracellular protein transport in other organism involved in symbiotic interaction(GO:0051708) |
| 0.5 |
0.5 |
GO:0009566 |
fertilization(GO:0009566) |
| 0.5 |
3.6 |
GO:0036336 |
dendritic cell chemotaxis(GO:0002407) dendritic cell migration(GO:0036336) |
| 0.4 |
1.3 |
GO:0001732 |
formation of cytoplasmic translation initiation complex(GO:0001732) cytoplasmic translation(GO:0002181) cytoplasmic translational initiation(GO:0002183) |
| 0.4 |
0.9 |
GO:0032527 |
retrograde protein transport, ER to cytosol(GO:0030970) protein exit from endoplasmic reticulum(GO:0032527) |
| 0.4 |
1.3 |
GO:0061302 |
smooth muscle cell-matrix adhesion(GO:0061302) |
| 0.4 |
1.3 |
GO:0031558 |
obsolete induction of apoptosis in response to chemical stimulus(GO:0031558) |
| 0.4 |
0.9 |
GO:0006855 |
drug transmembrane transport(GO:0006855) |
| 0.4 |
0.4 |
GO:0007007 |
inner mitochondrial membrane organization(GO:0007007) |
| 0.4 |
3.0 |
GO:0045040 |
outer mitochondrial membrane organization(GO:0007008) protein import into mitochondrial outer membrane(GO:0045040) |
| 0.4 |
1.7 |
GO:0051045 |
negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
| 0.4 |
8.6 |
GO:0015949 |
nucleobase-containing small molecule interconversion(GO:0015949) |
| 0.4 |
1.3 |
GO:0006432 |
phenylalanyl-tRNA aminoacylation(GO:0006432) |
| 0.4 |
1.3 |
GO:0044314 |
protein K27-linked ubiquitination(GO:0044314) |
| 0.4 |
0.4 |
GO:0016198 |
axon choice point recognition(GO:0016198) |
| 0.4 |
1.3 |
GO:0032938 |
negative regulation of translation in response to oxidative stress(GO:0032938) regulation of translation in response to oxidative stress(GO:0043556) |
| 0.4 |
31.3 |
GO:0045454 |
cell redox homeostasis(GO:0045454) |
| 0.4 |
1.3 |
GO:0090086 |
negative regulation of protein deubiquitination(GO:0090086) |
| 0.4 |
2.1 |
GO:0001778 |
plasma membrane repair(GO:0001778) |
| 0.4 |
1.3 |
GO:0008053 |
mitochondrial fusion(GO:0008053) |
| 0.4 |
0.4 |
GO:0048289 |
isotype switching to IgE isotypes(GO:0048289) regulation of isotype switching to IgE isotypes(GO:0048293) |
| 0.4 |
4.1 |
GO:0070374 |
positive regulation of ERK1 and ERK2 cascade(GO:0070374) |
| 0.4 |
2.1 |
GO:0018125 |
peptidyl-cysteine methylation(GO:0018125) |
| 0.4 |
2.1 |
GO:0045071 |
negative regulation of viral genome replication(GO:0045071) |
| 0.4 |
1.2 |
GO:0007000 |
nucleolus organization(GO:0007000) |
| 0.4 |
2.0 |
GO:0015693 |
magnesium ion transport(GO:0015693) |
| 0.4 |
4.1 |
GO:0006734 |
NADH metabolic process(GO:0006734) |
| 0.4 |
1.6 |
GO:0019322 |
pentose biosynthetic process(GO:0019322) |
| 0.4 |
1.6 |
GO:0032506 |
cytokinetic process(GO:0032506) |
| 0.4 |
0.4 |
GO:0021797 |
forebrain anterior/posterior pattern specification(GO:0021797) |
| 0.4 |
3.2 |
GO:0019614 |
phenol-containing compound catabolic process(GO:0019336) catechol-containing compound catabolic process(GO:0019614) catecholamine catabolic process(GO:0042424) |
| 0.4 |
1.2 |
GO:0045838 |
positive regulation of membrane potential(GO:0045838) |
| 0.4 |
1.6 |
GO:0006780 |
uroporphyrinogen III biosynthetic process(GO:0006780) |
| 0.4 |
0.4 |
GO:0045605 |
negative regulation of epidermal cell differentiation(GO:0045605) |
| 0.4 |
1.2 |
GO:0006597 |
spermine biosynthetic process(GO:0006597) |
| 0.4 |
1.6 |
GO:0060707 |
trophoblast giant cell differentiation(GO:0060707) |
| 0.4 |
0.8 |
GO:0051409 |
response to nitrosative stress(GO:0051409) |
| 0.4 |
1.2 |
GO:0060178 |
exocyst assembly(GO:0001927) regulation of exocyst assembly(GO:0001928) exocyst localization(GO:0051601) regulation of exocyst localization(GO:0060178) |
| 0.4 |
1.9 |
GO:0061003 |
positive regulation of dendritic spine morphogenesis(GO:0061003) |
| 0.4 |
1.2 |
GO:0010447 |
response to acidic pH(GO:0010447) |
| 0.4 |
0.4 |
GO:0097435 |
extracellular fibril organization(GO:0043206) fibril organization(GO:0097435) |
| 0.4 |
3.9 |
GO:0007141 |
male meiosis I(GO:0007141) |
| 0.4 |
3.1 |
GO:0007185 |
transmembrane receptor protein tyrosine phosphatase signaling pathway(GO:0007185) |
| 0.4 |
3.1 |
GO:0001706 |
endoderm formation(GO:0001706) |
| 0.4 |
2.7 |
GO:0060314 |
regulation of ryanodine-sensitive calcium-release channel activity(GO:0060314) |
| 0.4 |
1.2 |
GO:0000733 |
DNA strand renaturation(GO:0000733) |
| 0.4 |
4.6 |
GO:0032647 |
interferon-alpha production(GO:0032607) regulation of interferon-alpha production(GO:0032647) |
| 0.4 |
0.8 |
GO:0002513 |
tolerance induction to self antigen(GO:0002513) |
| 0.4 |
1.5 |
GO:0046477 |
glycosylceramide catabolic process(GO:0046477) |
| 0.4 |
0.8 |
GO:1903301 |
regulation of glucokinase activity(GO:0033131) positive regulation of glucokinase activity(GO:0033133) regulation of hexokinase activity(GO:1903299) positive regulation of hexokinase activity(GO:1903301) |
| 0.4 |
2.3 |
GO:0015853 |
adenine transport(GO:0015853) |
| 0.4 |
1.1 |
GO:0035330 |
regulation of hippo signaling(GO:0035330) |
| 0.4 |
2.6 |
GO:0071108 |
protein K48-linked deubiquitination(GO:0071108) |
| 0.4 |
0.7 |
GO:0060028 |
convergent extension involved in axis elongation(GO:0060028) |
| 0.4 |
1.9 |
GO:0045116 |
protein neddylation(GO:0045116) |
| 0.4 |
21.2 |
GO:0008064 |
regulation of actin polymerization or depolymerization(GO:0008064) |
| 0.4 |
0.4 |
GO:0003401 |
axis elongation(GO:0003401) |
| 0.4 |
0.4 |
GO:0045048 |
protein insertion into ER membrane(GO:0045048) tail-anchored membrane protein insertion into ER membrane(GO:0071816) |
| 0.4 |
1.5 |
GO:0001921 |
positive regulation of receptor recycling(GO:0001921) |
| 0.4 |
1.5 |
GO:0000394 |
RNA splicing, via endonucleolytic cleavage and ligation(GO:0000394) tRNA splicing, via endonucleolytic cleavage and ligation(GO:0006388) |
| 0.4 |
1.5 |
GO:0043248 |
proteasome assembly(GO:0043248) |
| 0.4 |
1.1 |
GO:0030091 |
protein repair(GO:0030091) |
| 0.4 |
4.7 |
GO:0090398 |
cellular senescence(GO:0090398) |
| 0.4 |
5.8 |
GO:0050812 |
acetyl-CoA biosynthetic process from pyruvate(GO:0006086) regulation of acetyl-CoA biosynthetic process from pyruvate(GO:0010510) regulation of acyl-CoA biosynthetic process(GO:0050812) |
| 0.4 |
2.9 |
GO:0019388 |
galactose catabolic process(GO:0019388) |
| 0.4 |
1.8 |
GO:0090343 |
positive regulation of cell aging(GO:0090343) |
| 0.4 |
3.2 |
GO:0051123 |
RNA polymerase II transcriptional preinitiation complex assembly(GO:0051123) DNA-templated transcriptional preinitiation complex assembly(GO:0070897) |
| 0.4 |
2.1 |
GO:0032472 |
cellular manganese ion homeostasis(GO:0030026) Golgi calcium ion homeostasis(GO:0032468) Golgi calcium ion transport(GO:0032472) manganese ion homeostasis(GO:0055071) |
| 0.4 |
2.8 |
GO:1903963 |
arachidonic acid secretion(GO:0050482) arachidonate transport(GO:1903963) |
| 0.4 |
3.9 |
GO:0045749 |
obsolete negative regulation of S phase of mitotic cell cycle(GO:0045749) |
| 0.4 |
1.1 |
GO:0045616 |
regulation of keratinocyte differentiation(GO:0045616) |
| 0.4 |
1.1 |
GO:0050765 |
negative regulation of phagocytosis(GO:0050765) |
| 0.3 |
1.0 |
GO:0071374 |
cellular response to parathyroid hormone stimulus(GO:0071374) |
| 0.3 |
1.4 |
GO:1901224 |
activation of NF-kappaB-inducing kinase activity(GO:0007250) NIK/NF-kappaB signaling(GO:0038061) regulation of NIK/NF-kappaB signaling(GO:1901222) positive regulation of NIK/NF-kappaB signaling(GO:1901224) |
| 0.3 |
0.7 |
GO:0070933 |
histone H3 deacetylation(GO:0070932) histone H4 deacetylation(GO:0070933) |
| 0.3 |
1.7 |
GO:0071157 |
negative regulation of cell cycle arrest(GO:0071157) |
| 0.3 |
1.0 |
GO:0032581 |
ER-dependent peroxisome organization(GO:0032581) |
| 0.3 |
1.7 |
GO:0071569 |
protein ufmylation(GO:0071569) |
| 0.3 |
1.7 |
GO:0072010 |
renal filtration cell differentiation(GO:0061318) glomerular epithelium development(GO:0072010) glomerular visceral epithelial cell differentiation(GO:0072112) glomerular epithelial cell differentiation(GO:0072311) |
| 0.3 |
1.7 |
GO:0007256 |
activation of JNKK activity(GO:0007256) |
| 0.3 |
0.3 |
GO:2000114 |
regulation of establishment of cell polarity(GO:2000114) |
| 0.3 |
0.7 |
GO:0034635 |
glutathione transport(GO:0034635) tripeptide transport(GO:0042939) |
| 0.3 |
1.0 |
GO:0001780 |
neutrophil homeostasis(GO:0001780) |
| 0.3 |
14.7 |
GO:0050690 |
regulation of defense response to virus by virus(GO:0050690) |
| 0.3 |
1.0 |
GO:0071277 |
cellular response to calcium ion(GO:0071277) |
| 0.3 |
6.3 |
GO:0007405 |
neuroblast proliferation(GO:0007405) |
| 0.3 |
0.3 |
GO:0043949 |
regulation of cAMP-mediated signaling(GO:0043949) |
| 0.3 |
0.7 |
GO:0060669 |
embryonic placenta morphogenesis(GO:0060669) labyrinthine layer morphogenesis(GO:0060713) |
| 0.3 |
0.7 |
GO:0031293 |
membrane protein intracellular domain proteolysis(GO:0031293) |
| 0.3 |
0.3 |
GO:0050807 |
regulation of synapse organization(GO:0050807) |
| 0.3 |
1.0 |
GO:0060023 |
soft palate development(GO:0060023) |
| 0.3 |
2.3 |
GO:0044341 |
sodium-dependent phosphate transport(GO:0044341) |
| 0.3 |
1.6 |
GO:0033261 |
obsolete regulation of S phase(GO:0033261) |
| 0.3 |
3.3 |
GO:0046629 |
gamma-delta T cell activation(GO:0046629) |
| 0.3 |
4.5 |
GO:0008625 |
extrinsic apoptotic signaling pathway via death domain receptors(GO:0008625) extrinsic apoptotic signaling pathway(GO:0097191) |
| 0.3 |
1.3 |
GO:0010765 |
positive regulation of sodium ion transport(GO:0010765) |
| 0.3 |
2.9 |
GO:0070206 |
protein trimerization(GO:0070206) |
| 0.3 |
3.6 |
GO:0042517 |
positive regulation of tyrosine phosphorylation of Stat3 protein(GO:0042517) |
| 0.3 |
2.3 |
GO:1903901 |
negative regulation of viral transcription(GO:0032897) negative regulation of viral process(GO:0048525) negative regulation of viral life cycle(GO:1903901) |
| 0.3 |
0.6 |
GO:0033089 |
positive regulation of T cell differentiation in thymus(GO:0033089) positive regulation of thymocyte aggregation(GO:2000400) |
| 0.3 |
1.6 |
GO:0019987 |
obsolete negative regulation of anti-apoptosis(GO:0019987) |
| 0.3 |
4.8 |
GO:0051496 |
positive regulation of stress fiber assembly(GO:0051496) |
| 0.3 |
4.5 |
GO:0071378 |
growth hormone receptor signaling pathway(GO:0060396) cellular response to growth hormone stimulus(GO:0071378) |
| 0.3 |
2.2 |
GO:0002726 |
positive regulation of T cell cytokine production(GO:0002726) |
| 0.3 |
1.9 |
GO:0071692 |
sequestering of extracellular ligand from receptor(GO:0035581) sequestering of TGFbeta in extracellular matrix(GO:0035583) protein localization to extracellular region(GO:0071692) maintenance of protein location in extracellular region(GO:0071694) extracellular regulation of signal transduction(GO:1900115) extracellular negative regulation of signal transduction(GO:1900116) |
| 0.3 |
1.3 |
GO:0046121 |
deoxyribonucleoside catabolic process(GO:0046121) |
| 0.3 |
1.3 |
GO:0048680 |
positive regulation of axon regeneration(GO:0048680) positive regulation of neuron projection regeneration(GO:0070572) |
| 0.3 |
6.9 |
GO:0016925 |
protein sumoylation(GO:0016925) |
| 0.3 |
4.7 |
GO:0032008 |
positive regulation of TOR signaling(GO:0032008) |
| 0.3 |
2.5 |
GO:0034394 |
protein localization to cell surface(GO:0034394) |
| 0.3 |
1.2 |
GO:0090267 |
positive regulation of spindle checkpoint(GO:0090232) regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090266) positive regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090267) positive regulation of cell cycle checkpoint(GO:1901978) regulation of mitotic spindle checkpoint(GO:1903504) |
| 0.3 |
0.3 |
GO:0042074 |
cell migration involved in gastrulation(GO:0042074) |
| 0.3 |
1.2 |
GO:0033522 |
histone H2A ubiquitination(GO:0033522) |
| 0.3 |
0.6 |
GO:0048478 |
replication fork protection(GO:0048478) |
| 0.3 |
3.1 |
GO:0048169 |
regulation of long-term neuronal synaptic plasticity(GO:0048169) |
| 0.3 |
0.3 |
GO:0060502 |
epithelial cell proliferation involved in lung morphogenesis(GO:0060502) |
| 0.3 |
2.5 |
GO:0045003 |
DNA recombinase assembly(GO:0000730) double-strand break repair via synthesis-dependent strand annealing(GO:0045003) |
| 0.3 |
0.6 |
GO:0090042 |
tubulin deacetylation(GO:0090042) |
| 0.3 |
2.1 |
GO:0045351 |
type I interferon biosynthetic process(GO:0045351) |
| 0.3 |
0.9 |
GO:0034551 |
respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) mitochondrial respiratory chain complex III biogenesis(GO:0097033) |
| 0.3 |
0.6 |
GO:0032106 |
positive regulation of response to extracellular stimulus(GO:0032106) positive regulation of response to nutrient levels(GO:0032109) |
| 0.3 |
0.3 |
GO:0001952 |
regulation of cell-matrix adhesion(GO:0001952) |
| 0.3 |
0.6 |
GO:0048630 |
skeletal muscle tissue growth(GO:0048630) |
| 0.3 |
0.3 |
GO:0035116 |
embryonic hindlimb morphogenesis(GO:0035116) |
| 0.3 |
0.3 |
GO:0002025 |
vasodilation by norepinephrine-epinephrine involved in regulation of systemic arterial blood pressure(GO:0002025) |
| 0.3 |
4.2 |
GO:0061036 |
positive regulation of cartilage development(GO:0061036) |
| 0.3 |
1.8 |
GO:0006703 |
estrogen biosynthetic process(GO:0006703) |
| 0.3 |
1.2 |
GO:0019046 |
release from viral latency(GO:0019046) |
| 0.3 |
0.6 |
GO:0032693 |
negative regulation of interleukin-10 production(GO:0032693) |
| 0.3 |
1.8 |
GO:0006658 |
phosphatidylserine metabolic process(GO:0006658) |
| 0.3 |
1.5 |
GO:0015862 |
uridine transport(GO:0015862) |
| 0.3 |
1.2 |
GO:0085020 |
protein K6-linked ubiquitination(GO:0085020) |
| 0.3 |
0.3 |
GO:0006679 |
glucosylceramide biosynthetic process(GO:0006679) |
| 0.3 |
0.9 |
GO:0070584 |
mitochondrion morphogenesis(GO:0070584) |
| 0.3 |
0.9 |
GO:0051102 |
DNA ligation involved in DNA recombination(GO:0051102) |
| 0.3 |
1.2 |
GO:0030252 |
growth hormone secretion(GO:0030252) |
| 0.3 |
0.3 |
GO:0010996 |
mechanosensory behavior(GO:0007638) response to auditory stimulus(GO:0010996) |
| 0.3 |
0.6 |
GO:0010002 |
cardioblast differentiation(GO:0010002) |
| 0.3 |
0.9 |
GO:0003077 |
obsolete negative regulation of diuresis(GO:0003077) |
| 0.3 |
2.0 |
GO:0048240 |
sperm capacitation(GO:0048240) |
| 0.3 |
3.4 |
GO:0046415 |
urate metabolic process(GO:0046415) |
| 0.3 |
0.9 |
GO:0060242 |
contact inhibition(GO:0060242) |
| 0.3 |
1.4 |
GO:1901984 |
negative regulation of histone acetylation(GO:0035067) negative regulation of protein acetylation(GO:1901984) negative regulation of peptidyl-lysine acetylation(GO:2000757) |
| 0.3 |
1.1 |
GO:0061526 |
acetylcholine secretion, neurotransmission(GO:0014055) regulation of acetylcholine secretion, neurotransmission(GO:0014056) acetylcholine secretion(GO:0061526) |
| 0.3 |
1.7 |
GO:0035335 |
peptidyl-tyrosine dephosphorylation(GO:0035335) |
| 0.3 |
1.4 |
GO:0032020 |
ISG15-protein conjugation(GO:0032020) |
| 0.3 |
6.5 |
GO:0006493 |
protein O-linked glycosylation(GO:0006493) |
| 0.3 |
0.8 |
GO:2000096 |
positive regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000096) |
| 0.3 |
4.5 |
GO:0060761 |
negative regulation of response to cytokine stimulus(GO:0060761) |
| 0.3 |
1.1 |
GO:0006196 |
AMP catabolic process(GO:0006196) |
| 0.3 |
0.3 |
GO:0002538 |
arachidonic acid metabolite production involved in inflammatory response(GO:0002538) leukotriene production involved in inflammatory response(GO:0002540) |
| 0.3 |
0.6 |
GO:0045046 |
protein import into peroxisome membrane(GO:0045046) |
| 0.3 |
5.0 |
GO:0006911 |
phagocytosis, engulfment(GO:0006911) membrane invagination(GO:0010324) |
| 0.3 |
2.0 |
GO:0001569 |
patterning of blood vessels(GO:0001569) |
| 0.3 |
3.9 |
GO:0006449 |
regulation of translational termination(GO:0006449) |
| 0.3 |
0.6 |
GO:0002674 |
negative regulation of acute inflammatory response(GO:0002674) |
| 0.3 |
0.3 |
GO:0060563 |
neuroepithelial cell differentiation(GO:0060563) |
| 0.3 |
0.5 |
GO:0048311 |
mitochondrion distribution(GO:0048311) |
| 0.3 |
0.5 |
GO:0090050 |
positive regulation of cell migration involved in sprouting angiogenesis(GO:0090050) positive regulation of sprouting angiogenesis(GO:1903672) |
| 0.3 |
0.3 |
GO:0015872 |
dopamine transport(GO:0015872) |
| 0.3 |
0.8 |
GO:0000729 |
DNA double-strand break processing(GO:0000729) |
| 0.3 |
2.5 |
GO:0033327 |
Leydig cell differentiation(GO:0033327) |
| 0.3 |
10.1 |
GO:0045740 |
positive regulation of DNA replication(GO:0045740) |
| 0.3 |
1.1 |
GO:0032229 |
negative regulation of synaptic transmission, GABAergic(GO:0032229) |
| 0.3 |
0.5 |
GO:0032713 |
negative regulation of interleukin-4 production(GO:0032713) |
| 0.3 |
1.3 |
GO:0051900 |
regulation of membrane depolarization(GO:0003254) mitochondrial depolarization(GO:0051882) regulation of mitochondrial depolarization(GO:0051900) |
| 0.3 |
0.5 |
GO:0001999 |
renal response to blood flow involved in circulatory renin-angiotensin regulation of systemic arterial blood pressure(GO:0001999) |
| 0.3 |
0.5 |
GO:0002532 |
production of molecular mediator involved in inflammatory response(GO:0002532) |
| 0.3 |
4.0 |
GO:0007220 |
Notch receptor processing(GO:0007220) |
| 0.3 |
1.3 |
GO:0050919 |
negative chemotaxis(GO:0050919) |
| 0.3 |
9.0 |
GO:0007193 |
adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway(GO:0007193) |
| 0.3 |
3.4 |
GO:0006700 |
C21-steroid hormone biosynthetic process(GO:0006700) |
| 0.3 |
2.1 |
GO:0045008 |
depyrimidination(GO:0045008) |
| 0.3 |
0.3 |
GO:0033683 |
nucleotide-excision repair, DNA incision(GO:0033683) |
| 0.3 |
0.8 |
GO:0000338 |
protein deneddylation(GO:0000338) |
| 0.3 |
0.5 |
GO:2000001 |
regulation of DNA damage checkpoint(GO:2000001) |
| 0.3 |
29.4 |
GO:0008544 |
epidermis development(GO:0008544) |
| 0.3 |
1.0 |
GO:0007096 |
regulation of exit from mitosis(GO:0007096) |
| 0.3 |
0.5 |
GO:0031573 |
intra-S DNA damage checkpoint(GO:0031573) |
| 0.3 |
12.8 |
GO:0051084 |
'de novo' posttranslational protein folding(GO:0051084) |
| 0.3 |
0.3 |
GO:0008037 |
cell recognition(GO:0008037) |
| 0.3 |
0.5 |
GO:0060748 |
tertiary branching involved in mammary gland duct morphogenesis(GO:0060748) |
| 0.3 |
1.3 |
GO:0030517 |
negative regulation of axon extension(GO:0030517) |
| 0.3 |
0.5 |
GO:0008356 |
asymmetric cell division(GO:0008356) |
| 0.3 |
0.3 |
GO:0005984 |
disaccharide metabolic process(GO:0005984) |
| 0.3 |
0.5 |
GO:0090047 |
obsolete positive regulation of transcription regulator activity(GO:0090047) |
| 0.3 |
1.3 |
GO:0046069 |
cGMP catabolic process(GO:0046069) |
| 0.3 |
5.3 |
GO:0043968 |
histone H2A acetylation(GO:0043968) |
| 0.3 |
0.8 |
GO:0031268 |
pseudopodium organization(GO:0031268) |
| 0.3 |
1.3 |
GO:0006012 |
galactose metabolic process(GO:0006012) |
| 0.3 |
1.0 |
GO:0006556 |
S-adenosylmethionine biosynthetic process(GO:0006556) |
| 0.3 |
0.5 |
GO:0032926 |
negative regulation of activin receptor signaling pathway(GO:0032926) |
| 0.2 |
4.5 |
GO:0002474 |
antigen processing and presentation of peptide antigen via MHC class I(GO:0002474) |
| 0.2 |
1.2 |
GO:0001866 |
NK T cell proliferation(GO:0001866) |
| 0.2 |
0.5 |
GO:0007412 |
axon target recognition(GO:0007412) |
| 0.2 |
0.5 |
GO:0051877 |
pigment granule aggregation in cell center(GO:0051877) |
| 0.2 |
2.7 |
GO:0043526 |
obsolete neuroprotection(GO:0043526) |
| 0.2 |
1.2 |
GO:0006290 |
pyrimidine dimer repair(GO:0006290) |
| 0.2 |
1.0 |
GO:0000103 |
sulfate assimilation(GO:0000103) |
| 0.2 |
3.7 |
GO:0007398 |
ectoderm development(GO:0007398) |
| 0.2 |
0.2 |
GO:0007418 |
ventral midline development(GO:0007418) |
| 0.2 |
0.7 |
GO:0032196 |
transposition, DNA-mediated(GO:0006313) transposition(GO:0032196) |
| 0.2 |
1.7 |
GO:0009313 |
oligosaccharide catabolic process(GO:0009313) |
| 0.2 |
0.5 |
GO:0006930 |
substrate-dependent cell migration, cell extension(GO:0006930) |
| 0.2 |
0.7 |
GO:0006348 |
chromatin silencing at telomere(GO:0006348) |
| 0.2 |
0.2 |
GO:0006323 |
DNA packaging(GO:0006323) |
| 0.2 |
0.7 |
GO:0045950 |
meiotic metaphase I plate congression(GO:0043060) negative regulation of mitotic recombination(GO:0045950) spindle midzone assembly(GO:0051255) meiotic spindle midzone assembly(GO:0051257) meiotic metaphase plate congression(GO:0051311) |
| 0.2 |
0.5 |
GO:0072148 |
epithelial cell fate commitment(GO:0072148) |
| 0.2 |
3.0 |
GO:0097031 |
NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
| 0.2 |
1.6 |
GO:0005978 |
glycogen biosynthetic process(GO:0005978) glucan biosynthetic process(GO:0009250) |
| 0.2 |
3.3 |
GO:0042596 |
fear response(GO:0042596) |
| 0.2 |
4.4 |
GO:0007032 |
endosome organization(GO:0007032) |
| 0.2 |
0.9 |
GO:0031503 |
protein complex localization(GO:0031503) |
| 0.2 |
6.2 |
GO:0006626 |
protein targeting to mitochondrion(GO:0006626) |
| 0.2 |
15.8 |
GO:0030521 |
androgen receptor signaling pathway(GO:0030521) |
| 0.2 |
0.5 |
GO:0016081 |
synaptic vesicle docking(GO:0016081) |
| 0.2 |
0.7 |
GO:0015870 |
acetylcholine transport(GO:0015870) acetate ester transport(GO:1901374) |
| 0.2 |
0.7 |
GO:0001574 |
ganglioside biosynthetic process(GO:0001574) |
| 0.2 |
28.5 |
GO:0007156 |
homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
| 0.2 |
3.8 |
GO:1901661 |
quinone metabolic process(GO:1901661) |
| 0.2 |
0.2 |
GO:0021544 |
subpallium development(GO:0021544) |
| 0.2 |
4.3 |
GO:0008633 |
obsolete activation of pro-apoptotic gene products(GO:0008633) |
| 0.2 |
0.7 |
GO:0042516 |
regulation of tyrosine phosphorylation of Stat3 protein(GO:0042516) |
| 0.2 |
0.2 |
GO:0002063 |
chondrocyte development(GO:0002063) |
| 0.2 |
14.9 |
GO:0008277 |
regulation of G-protein coupled receptor protein signaling pathway(GO:0008277) |
| 0.2 |
0.4 |
GO:0015670 |
carbon dioxide transport(GO:0015670) |
| 0.2 |
3.3 |
GO:0070534 |
protein K63-linked ubiquitination(GO:0070534) |
| 0.2 |
0.4 |
GO:0042271 |
susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
| 0.2 |
0.4 |
GO:0060428 |
lung epithelium development(GO:0060428) |
| 0.2 |
2.2 |
GO:0043278 |
response to isoquinoline alkaloid(GO:0014072) response to morphine(GO:0043278) |
| 0.2 |
4.1 |
GO:0030574 |
collagen catabolic process(GO:0030574) |
| 0.2 |
1.1 |
GO:0009235 |
cobalamin metabolic process(GO:0009235) |
| 0.2 |
0.2 |
GO:0015732 |
prostaglandin transport(GO:0015732) |
| 0.2 |
1.3 |
GO:0043330 |
response to exogenous dsRNA(GO:0043330) |
| 0.2 |
0.2 |
GO:0051894 |
positive regulation of focal adhesion assembly(GO:0051894) positive regulation of cell junction assembly(GO:1901890) positive regulation of adherens junction organization(GO:1903393) |
| 0.2 |
3.4 |
GO:0006297 |
nucleotide-excision repair, DNA gap filling(GO:0006297) |
| 0.2 |
2.8 |
GO:0043984 |
histone H4-K16 acetylation(GO:0043984) |
| 0.2 |
0.6 |
GO:0007341 |
penetration of zona pellucida(GO:0007341) |
| 0.2 |
1.5 |
GO:0009820 |
alkaloid metabolic process(GO:0009820) |
| 0.2 |
0.8 |
GO:0042986 |
positive regulation of amyloid precursor protein biosynthetic process(GO:0042986) |
| 0.2 |
0.4 |
GO:0051439 |
regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle(GO:0051439) |
| 0.2 |
3.8 |
GO:0008299 |
isoprenoid biosynthetic process(GO:0008299) |
| 0.2 |
1.0 |
GO:0006729 |
tetrahydrobiopterin biosynthetic process(GO:0006729) pteridine-containing compound biosynthetic process(GO:0042559) |
| 0.2 |
0.6 |
GO:0006382 |
adenosine to inosine editing(GO:0006382) |
| 0.2 |
1.2 |
GO:0031943 |
regulation of glucocorticoid metabolic process(GO:0031943) |
| 0.2 |
4.8 |
GO:0042776 |
mitochondrial ATP synthesis coupled proton transport(GO:0042776) |
| 0.2 |
6.6 |
GO:0006283 |
transcription-coupled nucleotide-excision repair(GO:0006283) |
| 0.2 |
0.4 |
GO:0071392 |
cellular response to estradiol stimulus(GO:0071392) |
| 0.2 |
0.4 |
GO:2001022 |
positive regulation of response to DNA damage stimulus(GO:2001022) |
| 0.2 |
2.0 |
GO:0006002 |
fructose 6-phosphate metabolic process(GO:0006002) |
| 0.2 |
0.4 |
GO:1904748 |
regulation of apoptotic process involved in morphogenesis(GO:1902337) regulation of apoptotic process involved in development(GO:1904748) |
| 0.2 |
0.6 |
GO:0009134 |
nucleoside diphosphate catabolic process(GO:0009134) ribonucleoside diphosphate catabolic process(GO:0009191) |
| 0.2 |
0.2 |
GO:0050829 |
defense response to Gram-negative bacterium(GO:0050829) |
| 0.2 |
0.6 |
GO:0006423 |
cysteinyl-tRNA aminoacylation(GO:0006423) |
| 0.2 |
0.2 |
GO:0019886 |
antigen processing and presentation of exogenous peptide antigen via MHC class II(GO:0019886) |
| 0.2 |
0.2 |
GO:0048861 |
leukemia inhibitory factor signaling pathway(GO:0048861) |
| 0.2 |
1.8 |
GO:0090083 |
regulation of inclusion body assembly(GO:0090083) |
| 0.2 |
0.6 |
GO:0001661 |
conditioned taste aversion(GO:0001661) |
| 0.2 |
1.4 |
GO:0009396 |
folic acid-containing compound biosynthetic process(GO:0009396) |
| 0.2 |
0.4 |
GO:0046487 |
glyoxylate metabolic process(GO:0046487) |
| 0.2 |
0.6 |
GO:0050858 |
negative regulation of antigen receptor-mediated signaling pathway(GO:0050858) negative regulation of T cell receptor signaling pathway(GO:0050860) |
| 0.2 |
0.6 |
GO:0034204 |
lipid translocation(GO:0034204) phospholipid translocation(GO:0045332) |
| 0.2 |
0.6 |
GO:0001974 |
blood vessel remodeling(GO:0001974) |
| 0.2 |
0.4 |
GO:0070585 |
protein localization to mitochondrion(GO:0070585) |
| 0.2 |
0.2 |
GO:0000059 |
protein import into nucleus, docking(GO:0000059) |
| 0.2 |
0.4 |
GO:0002043 |
blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:0002043) |
| 0.2 |
28.5 |
GO:0042787 |
protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0042787) |
| 0.2 |
0.6 |
GO:0042756 |
drinking behavior(GO:0042756) |
| 0.2 |
1.1 |
GO:0043316 |
natural killer cell activation involved in immune response(GO:0002323) cytotoxic T cell degranulation(GO:0043316) natural killer cell degranulation(GO:0043320) |
| 0.2 |
0.2 |
GO:0006085 |
acetyl-CoA biosynthetic process(GO:0006085) |
| 0.2 |
0.8 |
GO:0031958 |
corticosteroid receptor signaling pathway(GO:0031958) glucocorticoid receptor signaling pathway(GO:0042921) |
| 0.2 |
0.4 |
GO:0032682 |
negative regulation of chemokine production(GO:0032682) |
| 0.2 |
0.6 |
GO:0003341 |
cilium movement(GO:0003341) |
| 0.2 |
0.2 |
GO:0070935 |
3'-UTR-mediated mRNA stabilization(GO:0070935) |
| 0.2 |
0.2 |
GO:0009441 |
glycolate metabolic process(GO:0009441) |
| 0.2 |
0.7 |
GO:0006122 |
mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
| 0.2 |
0.4 |
GO:1903523 |
negative regulation of blood circulation(GO:1903523) |
| 0.2 |
1.1 |
GO:0006177 |
GMP biosynthetic process(GO:0006177) |
| 0.2 |
1.1 |
GO:0031290 |
retinal ganglion cell axon guidance(GO:0031290) |
| 0.2 |
0.6 |
GO:0050917 |
sensory perception of umami taste(GO:0050917) |
| 0.2 |
0.9 |
GO:0019372 |
lipoxygenase pathway(GO:0019372) |
| 0.2 |
2.6 |
GO:0019233 |
sensory perception of pain(GO:0019233) |
| 0.2 |
0.4 |
GO:0010713 |
negative regulation of collagen metabolic process(GO:0010713) negative regulation of multicellular organismal metabolic process(GO:0044252) MHC class I biosynthetic process(GO:0045341) regulation of MHC class I biosynthetic process(GO:0045343) |
| 0.2 |
6.2 |
GO:0046847 |
filopodium assembly(GO:0046847) |
| 0.2 |
5.3 |
GO:0050909 |
sensory perception of taste(GO:0050909) |
| 0.2 |
0.5 |
GO:0048096 |
chromatin-mediated maintenance of transcription(GO:0048096) |
| 0.2 |
0.9 |
GO:0045823 |
positive regulation of heart contraction(GO:0045823) |
| 0.2 |
0.7 |
GO:0006668 |
sphinganine-1-phosphate metabolic process(GO:0006668) |
| 0.2 |
1.1 |
GO:0030101 |
natural killer cell activation(GO:0030101) |
| 0.2 |
0.5 |
GO:0043012 |
regulation of fusion of sperm to egg plasma membrane(GO:0043012) |
| 0.2 |
0.5 |
GO:0050435 |
beta-amyloid metabolic process(GO:0050435) |
| 0.2 |
0.7 |
GO:0060456 |
positive regulation of digestive system process(GO:0060456) |
| 0.2 |
1.1 |
GO:0045059 |
positive thymic T cell selection(GO:0045059) |
| 0.2 |
0.9 |
GO:0001514 |
selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
| 0.2 |
1.6 |
GO:0001542 |
ovulation from ovarian follicle(GO:0001542) |
| 0.2 |
1.9 |
GO:0031146 |
SCF-dependent proteasomal ubiquitin-dependent protein catabolic process(GO:0031146) |
| 0.2 |
0.7 |
GO:0030330 |
DNA damage response, signal transduction by p53 class mediator(GO:0030330) |
| 0.2 |
0.5 |
GO:0018344 |
protein geranylgeranylation(GO:0018344) |
| 0.2 |
0.2 |
GO:0050653 |
dermatan sulfate proteoglycan biosynthetic process(GO:0050651) chondroitin sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0050653) dermatan sulfate proteoglycan metabolic process(GO:0050655) |
| 0.2 |
2.9 |
GO:0070979 |
protein K11-linked ubiquitination(GO:0070979) |
| 0.2 |
0.3 |
GO:0046469 |
platelet activating factor metabolic process(GO:0046469) |
| 0.2 |
4.2 |
GO:0050931 |
melanocyte differentiation(GO:0030318) pigment cell differentiation(GO:0050931) |
| 0.2 |
0.5 |
GO:0019853 |
L-ascorbic acid biosynthetic process(GO:0019853) |
| 0.2 |
0.5 |
GO:0048304 |
positive regulation of isotype switching to IgG isotypes(GO:0048304) |
| 0.2 |
0.7 |
GO:0043457 |
regulation of cellular respiration(GO:0043457) |
| 0.2 |
0.7 |
GO:0006477 |
protein sulfation(GO:0006477) |
| 0.2 |
0.3 |
GO:0000244 |
spliceosomal tri-snRNP complex assembly(GO:0000244) |
| 0.2 |
0.2 |
GO:0051482 |
positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway(GO:0051482) |
| 0.2 |
0.2 |
GO:0060363 |
cranial suture morphogenesis(GO:0060363) craniofacial suture morphogenesis(GO:0097094) |
| 0.2 |
0.2 |
GO:0032672 |
regulation of interleukin-3 production(GO:0032672) positive regulation of interleukin-3 production(GO:0032752) interleukin-3 biosynthetic process(GO:0042223) regulation of interleukin-3 biosynthetic process(GO:0045399) positive regulation of interleukin-3 biosynthetic process(GO:0045401) |
| 0.2 |
2.3 |
GO:1903321 |
negative regulation of protein modification by small protein conjugation or removal(GO:1903321) |
| 0.2 |
1.0 |
GO:0030260 |
entry into host cell(GO:0030260) entry into host(GO:0044409) entry into cell of other organism involved in symbiotic interaction(GO:0051806) entry into other organism involved in symbiotic interaction(GO:0051828) |
| 0.2 |
0.3 |
GO:0032627 |
interleukin-23 production(GO:0032627) regulation of interleukin-23 production(GO:0032667) |
| 0.2 |
0.2 |
GO:0001878 |
response to yeast(GO:0001878) |
| 0.2 |
10.4 |
GO:0006821 |
chloride transport(GO:0006821) |
| 0.2 |
0.3 |
GO:0046835 |
carbohydrate phosphorylation(GO:0046835) |
| 0.2 |
1.5 |
GO:0042730 |
fibrinolysis(GO:0042730) |
| 0.2 |
1.6 |
GO:0008542 |
visual learning(GO:0008542) |
| 0.2 |
0.6 |
GO:0010457 |
centriole-centriole cohesion(GO:0010457) |
| 0.2 |
0.2 |
GO:0021521 |
ventral spinal cord interneuron specification(GO:0021521) cell fate specification involved in pattern specification(GO:0060573) |
| 0.2 |
1.1 |
GO:0006885 |
regulation of pH(GO:0006885) |
| 0.2 |
0.6 |
GO:0007635 |
chemosensory behavior(GO:0007635) |
| 0.2 |
0.3 |
GO:0072334 |
UDP-galactose transport(GO:0015785) UDP-galactose transmembrane transport(GO:0072334) pyrimidine nucleotide-sugar transmembrane transport(GO:0090481) nucleotide transmembrane transport(GO:1901679) |
| 0.2 |
0.6 |
GO:0006726 |
eye pigment biosynthetic process(GO:0006726) eye pigment metabolic process(GO:0042441) pigment metabolic process involved in developmental pigmentation(GO:0043324) pigment metabolic process involved in pigmentation(GO:0043474) |
| 0.2 |
0.5 |
GO:0002921 |
negative regulation of humoral immune response(GO:0002921) negative regulation of protein processing(GO:0010955) negative regulation of protein maturation(GO:1903318) |
| 0.2 |
0.6 |
GO:0007506 |
gonadal mesoderm development(GO:0007506) |
| 0.2 |
0.5 |
GO:1903008 |
organelle disassembly(GO:1903008) |
| 0.2 |
0.3 |
GO:0010891 |
negative regulation of sequestering of triglyceride(GO:0010891) |
| 0.2 |
1.4 |
GO:0007016 |
cytoskeletal anchoring at plasma membrane(GO:0007016) |
| 0.2 |
0.2 |
GO:0032233 |
positive regulation of actin filament bundle assembly(GO:0032233) |
| 0.2 |
2.1 |
GO:0030856 |
regulation of epithelial cell differentiation(GO:0030856) |
| 0.2 |
0.2 |
GO:0045026 |
plasma membrane fusion(GO:0045026) |
| 0.2 |
0.2 |
GO:0033630 |
positive regulation of cell adhesion mediated by integrin(GO:0033630) |
| 0.2 |
0.3 |
GO:0002328 |
pro-B cell differentiation(GO:0002328) |
| 0.1 |
1.2 |
GO:0048268 |
clathrin coat assembly(GO:0048268) |
| 0.1 |
1.3 |
GO:0060512 |
prostate gland morphogenesis(GO:0060512) |
| 0.1 |
0.4 |
GO:0051083 |
'de novo' cotranslational protein folding(GO:0051083) |
| 0.1 |
0.4 |
GO:0030488 |
tRNA methylation(GO:0030488) |
| 0.1 |
1.5 |
GO:0033138 |
positive regulation of peptidyl-serine phosphorylation(GO:0033138) |
| 0.1 |
0.4 |
GO:0046502 |
uroporphyrinogen III metabolic process(GO:0046502) |
| 0.1 |
1.0 |
GO:0015780 |
nucleotide-sugar transport(GO:0015780) |
| 0.1 |
1.2 |
GO:1903050 |
regulation of proteolysis involved in cellular protein catabolic process(GO:1903050) |
| 0.1 |
0.3 |
GO:0048485 |
autonomic nervous system development(GO:0048483) sympathetic nervous system development(GO:0048485) |
| 0.1 |
1.5 |
GO:0008038 |
neuron recognition(GO:0008038) |
| 0.1 |
0.6 |
GO:0018206 |
peptidyl-methionine modification(GO:0018206) |
| 0.1 |
0.3 |
GO:0006707 |
cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
| 0.1 |
0.1 |
GO:0051096 |
regulation of helicase activity(GO:0051095) positive regulation of helicase activity(GO:0051096) |
| 0.1 |
1.4 |
GO:0006376 |
mRNA splice site selection(GO:0006376) |
| 0.1 |
0.1 |
GO:0090218 |
positive regulation of lipid kinase activity(GO:0090218) |
| 0.1 |
0.4 |
GO:0018874 |
benzoate metabolic process(GO:0018874) |
| 0.1 |
1.3 |
GO:0006891 |
intra-Golgi vesicle-mediated transport(GO:0006891) |
| 0.1 |
0.3 |
GO:0000301 |
retrograde transport, vesicle recycling within Golgi(GO:0000301) |
| 0.1 |
0.3 |
GO:0050775 |
positive regulation of dendrite morphogenesis(GO:0050775) |
| 0.1 |
0.1 |
GO:1902414 |
protein localization to adherens junction(GO:0071896) protein localization to cell junction(GO:1902414) |
| 0.1 |
1.5 |
GO:0009409 |
response to cold(GO:0009409) |
| 0.1 |
7.8 |
GO:0008033 |
tRNA processing(GO:0008033) |
| 0.1 |
0.3 |
GO:0006863 |
purine nucleobase transport(GO:0006863) pyrimidine nucleobase transport(GO:0015855) |
| 0.1 |
0.4 |
GO:0051103 |
DNA ligation involved in DNA repair(GO:0051103) |
| 0.1 |
0.3 |
GO:0060177 |
regulation of angiotensin metabolic process(GO:0060177) |
| 0.1 |
0.5 |
GO:0045161 |
neuronal ion channel clustering(GO:0045161) |
| 0.1 |
0.5 |
GO:0034337 |
RNA folding(GO:0034337) DNA hypomethylation(GO:0044028) hypomethylation of CpG island(GO:0044029) regulation of DNA methylation(GO:0044030) |
| 0.1 |
0.5 |
GO:0035121 |
obsolete tail morphogenesis(GO:0035121) |
| 0.1 |
0.1 |
GO:0009211 |
pyrimidine deoxyribonucleoside triphosphate metabolic process(GO:0009211) |
| 0.1 |
1.7 |
GO:0050873 |
brown fat cell differentiation(GO:0050873) |
| 0.1 |
0.8 |
GO:0006931 |
substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
| 0.1 |
0.1 |
GO:0050968 |
detection of chemical stimulus involved in sensory perception of pain(GO:0050968) |
| 0.1 |
2.9 |
GO:0032480 |
negative regulation of type I interferon production(GO:0032480) |
| 0.1 |
0.8 |
GO:0048488 |
synaptic vesicle recycling(GO:0036465) synaptic vesicle endocytosis(GO:0048488) clathrin-mediated endocytosis(GO:0072583) |
| 0.1 |
6.1 |
GO:0006120 |
mitochondrial electron transport, NADH to ubiquinone(GO:0006120) |
| 0.1 |
0.3 |
GO:0031034 |
skeletal muscle myosin thick filament assembly(GO:0030241) myosin filament organization(GO:0031033) myosin filament assembly(GO:0031034) striated muscle myosin thick filament assembly(GO:0071688) |
| 0.1 |
0.1 |
GO:1901998 |
antibiotic transport(GO:0042891) toxin transport(GO:1901998) |
| 0.1 |
1.0 |
GO:0030511 |
positive regulation of transforming growth factor beta receptor signaling pathway(GO:0030511) positive regulation of cellular response to transforming growth factor beta stimulus(GO:1903846) |
| 0.1 |
2.1 |
GO:0008156 |
negative regulation of DNA replication(GO:0008156) |
| 0.1 |
0.4 |
GO:0043490 |
malate-aspartate shuttle(GO:0043490) |
| 0.1 |
1.4 |
GO:0043496 |
regulation of protein homodimerization activity(GO:0043496) |
| 0.1 |
0.3 |
GO:0060992 |
response to fungicide(GO:0060992) |
| 0.1 |
0.1 |
GO:0035050 |
embryonic heart tube development(GO:0035050) |
| 0.1 |
0.3 |
GO:0046184 |
aldehyde biosynthetic process(GO:0046184) |
| 0.1 |
0.8 |
GO:0008333 |
endosome to lysosome transport(GO:0008333) |
| 0.1 |
0.3 |
GO:0021520 |
spinal cord motor neuron cell fate specification(GO:0021520) |
| 0.1 |
16.2 |
GO:0006184 |
obsolete GTP catabolic process(GO:0006184) |
| 0.1 |
0.9 |
GO:0008340 |
determination of adult lifespan(GO:0008340) |
| 0.1 |
0.1 |
GO:0045347 |
negative regulation of MHC class II biosynthetic process(GO:0045347) |
| 0.1 |
0.4 |
GO:0000154 |
rRNA modification(GO:0000154) |
| 0.1 |
0.1 |
GO:0016576 |
histone dephosphorylation(GO:0016576) |
| 0.1 |
0.6 |
GO:0045948 |
positive regulation of translational initiation(GO:0045948) |
| 0.1 |
0.1 |
GO:0051155 |
positive regulation of striated muscle cell differentiation(GO:0051155) |
| 0.1 |
0.9 |
GO:0032957 |
inositol trisphosphate metabolic process(GO:0032957) |
| 0.1 |
0.2 |
GO:0018377 |
N-terminal protein myristoylation(GO:0006499) protein myristoylation(GO:0018377) |
| 0.1 |
0.5 |
GO:0001522 |
pseudouridine synthesis(GO:0001522) |
| 0.1 |
0.2 |
GO:0021513 |
spinal cord dorsal/ventral patterning(GO:0021513) |
| 0.1 |
2.3 |
GO:0032200 |
telomere organization(GO:0032200) |
| 0.1 |
5.0 |
GO:0001525 |
angiogenesis(GO:0001525) |
| 0.1 |
1.3 |
GO:0043567 |
regulation of insulin-like growth factor receptor signaling pathway(GO:0043567) |
| 0.1 |
0.7 |
GO:0015742 |
alpha-ketoglutarate transport(GO:0015742) |
| 0.1 |
0.9 |
GO:0017156 |
calcium ion regulated exocytosis(GO:0017156) |
| 0.1 |
14.1 |
GO:0043123 |
positive regulation of I-kappaB kinase/NF-kappaB signaling(GO:0043123) |
| 0.1 |
0.5 |
GO:0006384 |
transcription initiation from RNA polymerase III promoter(GO:0006384) |
| 0.1 |
0.6 |
GO:0060414 |
aorta development(GO:0035904) aorta morphogenesis(GO:0035909) aorta smooth muscle tissue morphogenesis(GO:0060414) |
| 0.1 |
0.1 |
GO:0006498 |
N-terminal protein lipidation(GO:0006498) |
| 0.1 |
0.1 |
GO:0070989 |
oxidative demethylation(GO:0070989) |
| 0.1 |
0.9 |
GO:0015985 |
energy coupled proton transport, down electrochemical gradient(GO:0015985) ATP synthesis coupled proton transport(GO:0015986) |
| 0.1 |
0.1 |
GO:0032095 |
regulation of response to food(GO:0032095) |
| 0.1 |
0.1 |
GO:0009698 |
phenylpropanoid metabolic process(GO:0009698) coumarin metabolic process(GO:0009804) |
| 0.1 |
0.3 |
GO:0060218 |
hematopoietic stem cell differentiation(GO:0060218) |
| 0.1 |
2.5 |
GO:0046834 |
lipid phosphorylation(GO:0046834) |
| 0.1 |
0.2 |
GO:0035020 |
regulation of Rac protein signal transduction(GO:0035020) |
| 0.1 |
0.3 |
GO:0032091 |
negative regulation of protein binding(GO:0032091) |
| 0.1 |
2.3 |
GO:0006501 |
C-terminal protein lipidation(GO:0006501) preassembly of GPI anchor in ER membrane(GO:0016254) |
| 0.1 |
2.9 |
GO:0051156 |
glucose 6-phosphate metabolic process(GO:0051156) |
| 0.1 |
1.4 |
GO:0034605 |
cellular response to heat(GO:0034605) |
| 0.1 |
0.4 |
GO:0008295 |
spermidine biosynthetic process(GO:0008295) |
| 0.1 |
0.3 |
GO:0016098 |
monoterpenoid metabolic process(GO:0016098) |
| 0.1 |
0.2 |
GO:0010155 |
regulation of proton transport(GO:0010155) |
| 0.1 |
0.2 |
GO:0032236 |
obsolete positive regulation of calcium ion transport via store-operated calcium channel activity(GO:0032236) |
| 0.1 |
0.7 |
GO:0033119 |
negative regulation of RNA splicing(GO:0033119) |
| 0.1 |
0.4 |
GO:0071025 |
RNA surveillance(GO:0071025) nuclear RNA surveillance(GO:0071027) nuclear mRNA surveillance(GO:0071028) |
| 0.1 |
0.3 |
GO:0006207 |
'de novo' pyrimidine nucleobase biosynthetic process(GO:0006207) pyrimidine nucleobase biosynthetic process(GO:0019856) |
| 0.1 |
0.1 |
GO:2001259 |
positive regulation of calcium ion transmembrane transporter activity(GO:1901021) positive regulation of cation channel activity(GO:2001259) |
| 0.1 |
0.5 |
GO:0008344 |
adult locomotory behavior(GO:0008344) |
| 0.1 |
4.0 |
GO:0000079 |
regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0000079) regulation of cyclin-dependent protein kinase activity(GO:1904029) |
| 0.1 |
0.3 |
GO:0016926 |
protein desumoylation(GO:0016926) |
| 0.1 |
0.3 |
GO:0051100 |
negative regulation of binding(GO:0051100) |
| 0.1 |
0.3 |
GO:0007288 |
sperm axoneme assembly(GO:0007288) |
| 0.1 |
0.3 |
GO:0050747 |
positive regulation of lipoprotein metabolic process(GO:0050747) |
| 0.1 |
0.4 |
GO:0070295 |
renal water absorption(GO:0070295) |
| 0.1 |
1.2 |
GO:0000018 |
regulation of DNA recombination(GO:0000018) |
| 0.1 |
0.4 |
GO:0032528 |
microvillus assembly(GO:0030033) microvillus organization(GO:0032528) |
| 0.1 |
0.6 |
GO:0090278 |
negative regulation of peptide secretion(GO:0002792) negative regulation of peptide hormone secretion(GO:0090278) |
| 0.1 |
0.5 |
GO:0009164 |
nucleoside catabolic process(GO:0009164) |
| 0.1 |
0.1 |
GO:0035455 |
response to interferon-alpha(GO:0035455) |
| 0.1 |
0.4 |
GO:0006848 |
pyruvate transport(GO:0006848) |
| 0.1 |
0.3 |
GO:0045065 |
cytotoxic T cell differentiation(GO:0045065) |
| 0.1 |
0.6 |
GO:0006264 |
mitochondrial DNA replication(GO:0006264) |
| 0.1 |
2.5 |
GO:1902600 |
hydrogen ion transmembrane transport(GO:1902600) |
| 0.1 |
0.4 |
GO:0006540 |
glutamate decarboxylation to succinate(GO:0006540) |
| 0.1 |
1.9 |
GO:0007030 |
Golgi organization(GO:0007030) |
| 0.1 |
0.8 |
GO:0000076 |
DNA replication checkpoint(GO:0000076) |
| 0.1 |
2.0 |
GO:0006730 |
one-carbon metabolic process(GO:0006730) |
| 0.1 |
0.5 |
GO:0043508 |
negative regulation of JUN kinase activity(GO:0043508) |
| 0.1 |
2.4 |
GO:0006939 |
smooth muscle contraction(GO:0006939) |
| 0.1 |
0.4 |
GO:0046386 |
deoxyribonucleotide catabolic process(GO:0009264) deoxyribose phosphate catabolic process(GO:0046386) |
| 0.1 |
1.5 |
GO:0050832 |
defense response to fungus(GO:0050832) |
| 0.1 |
0.7 |
GO:0001539 |
cilium or flagellum-dependent cell motility(GO:0001539) |
| 0.1 |
0.7 |
GO:0002381 |
somatic recombination of immunoglobulin genes involved in immune response(GO:0002204) somatic diversification of immunoglobulins involved in immune response(GO:0002208) immunoglobulin production involved in immunoglobulin mediated immune response(GO:0002381) isotype switching(GO:0045190) |
| 0.1 |
0.4 |
GO:0098927 |
early endosome to late endosome transport(GO:0045022) vesicle-mediated transport between endosomal compartments(GO:0098927) |
| 0.1 |
0.2 |
GO:0043369 |
positive regulation of defense response to virus by host(GO:0002230) alpha-beta T cell lineage commitment(GO:0002363) CD4-positive or CD8-positive, alpha-beta T cell lineage commitment(GO:0043369) |
| 0.1 |
0.2 |
GO:0097237 |
response to cobalt ion(GO:0032025) cellular response to antibiotic(GO:0071236) cellular response to toxic substance(GO:0097237) |
| 0.1 |
0.4 |
GO:0021978 |
telencephalon regionalization(GO:0021978) |
| 0.1 |
2.5 |
GO:0050434 |
positive regulation of viral transcription(GO:0050434) |
| 0.1 |
0.2 |
GO:0007199 |
G-protein coupled receptor signaling pathway coupled to cGMP nucleotide second messenger(GO:0007199) |
| 0.1 |
0.9 |
GO:0045907 |
positive regulation of vasoconstriction(GO:0045907) |
| 0.1 |
0.4 |
GO:0051958 |
methotrexate transport(GO:0051958) |
| 0.1 |
0.6 |
GO:0072378 |
blood coagulation, fibrin clot formation(GO:0072378) |
| 0.1 |
0.5 |
GO:0021516 |
dorsal spinal cord development(GO:0021516) |
| 0.1 |
0.1 |
GO:0032731 |
positive regulation of interleukin-1 beta production(GO:0032731) |
| 0.1 |
1.8 |
GO:0042267 |
natural killer cell mediated immunity(GO:0002228) natural killer cell mediated cytotoxicity(GO:0042267) |
| 0.1 |
0.1 |
GO:0015889 |
cobalamin transport(GO:0015889) |
| 0.1 |
0.9 |
GO:0016180 |
snRNA processing(GO:0016180) |
| 0.1 |
0.4 |
GO:0060638 |
mesenchymal-epithelial cell signaling(GO:0060638) |
| 0.1 |
0.2 |
GO:0071482 |
cellular response to light stimulus(GO:0071482) |
| 0.1 |
0.6 |
GO:0010833 |
telomere maintenance via telomere lengthening(GO:0010833) |
| 0.1 |
0.3 |
GO:0072387 |
flavin adenine dinucleotide metabolic process(GO:0072387) |
| 0.1 |
0.2 |
GO:0016056 |
rhodopsin mediated signaling pathway(GO:0016056) |
| 0.1 |
0.9 |
GO:0001709 |
cell fate determination(GO:0001709) |
| 0.1 |
0.3 |
GO:0007210 |
serotonin receptor signaling pathway(GO:0007210) |
| 0.1 |
0.2 |
GO:0010919 |
regulation of inositol phosphate biosynthetic process(GO:0010919) |
| 0.1 |
0.5 |
GO:0051131 |
chaperone-mediated protein complex assembly(GO:0051131) |
| 0.1 |
1.7 |
GO:0030224 |
monocyte differentiation(GO:0030224) |
| 0.1 |
0.3 |
GO:0033539 |
fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
| 0.1 |
0.3 |
GO:0045475 |
locomotor rhythm(GO:0045475) |
| 0.1 |
0.6 |
GO:0007041 |
lysosomal transport(GO:0007041) |
| 0.1 |
0.3 |
GO:0043473 |
pigmentation(GO:0043473) |
| 0.1 |
0.5 |
GO:0007258 |
JUN phosphorylation(GO:0007258) |
| 0.1 |
0.1 |
GO:0045880 |
positive regulation of smoothened signaling pathway(GO:0045880) |
| 0.1 |
0.2 |
GO:0001757 |
somite specification(GO:0001757) |
| 0.1 |
0.6 |
GO:0070536 |
protein K63-linked deubiquitination(GO:0070536) |
| 0.1 |
0.2 |
GO:0046500 |
S-adenosylmethionine metabolic process(GO:0046500) |
| 0.1 |
0.2 |
GO:0045715 |
negative regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045715) |
| 0.1 |
4.4 |
GO:0016197 |
endosomal transport(GO:0016197) |
| 0.1 |
0.7 |
GO:0033523 |
histone H2B ubiquitination(GO:0033523) |
| 0.1 |
0.5 |
GO:0007567 |
parturition(GO:0007567) |
| 0.1 |
0.3 |
GO:0071044 |
histone mRNA catabolic process(GO:0071044) |
| 0.1 |
0.2 |
GO:0007079 |
mitotic chromosome movement towards spindle pole(GO:0007079) chromosome movement towards spindle pole(GO:0051305) |
| 0.1 |
0.8 |
GO:0007530 |
sex determination(GO:0007530) |
| 0.1 |
0.2 |
GO:0060831 |
smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:0060831) |
| 0.1 |
3.0 |
GO:0043484 |
regulation of RNA splicing(GO:0043484) |
| 0.1 |
0.2 |
GO:0034723 |
DNA replication-dependent nucleosome organization(GO:0034723) |
| 0.1 |
0.2 |
GO:0016265 |
obsolete death(GO:0016265) |
| 0.1 |
0.4 |
GO:0034616 |
response to laminar fluid shear stress(GO:0034616) |
| 0.1 |
0.1 |
GO:1901160 |
serotonin metabolic process(GO:0042428) primary amino compound metabolic process(GO:1901160) |
| 0.1 |
0.1 |
GO:0050432 |
catecholamine secretion(GO:0050432) |
| 0.1 |
1.5 |
GO:0000291 |
nuclear-transcribed mRNA catabolic process, exonucleolytic(GO:0000291) exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay(GO:0043928) |
| 0.1 |
1.8 |
GO:0045727 |
positive regulation of cellular amide metabolic process(GO:0034250) positive regulation of translation(GO:0045727) |
| 0.1 |
0.1 |
GO:0006971 |
hypotonic response(GO:0006971) |
| 0.1 |
0.3 |
GO:0050928 |
Tie signaling pathway(GO:0048014) negative regulation of positive chemotaxis(GO:0050928) |
| 0.1 |
0.1 |
GO:0032075 |
positive regulation of nuclease activity(GO:0032075) |
| 0.1 |
1.0 |
GO:0042116 |
macrophage activation(GO:0042116) |
| 0.1 |
0.2 |
GO:0009880 |
embryonic pattern specification(GO:0009880) |
| 0.1 |
0.4 |
GO:0030041 |
actin filament polymerization(GO:0030041) |
| 0.1 |
5.4 |
GO:0006413 |
translational initiation(GO:0006413) |
| 0.1 |
3.2 |
GO:0006892 |
post-Golgi vesicle-mediated transport(GO:0006892) |
| 0.1 |
0.1 |
GO:0006307 |
DNA dealkylation involved in DNA repair(GO:0006307) DNA dealkylation(GO:0035510) |
| 0.1 |
0.2 |
GO:0060271 |
cilium morphogenesis(GO:0060271) |
| 0.1 |
3.9 |
GO:0006367 |
transcription initiation from RNA polymerase II promoter(GO:0006367) |
| 0.1 |
0.3 |
GO:0009268 |
response to pH(GO:0009268) |
| 0.1 |
0.1 |
GO:0070781 |
response to biotin(GO:0070781) |
| 0.1 |
0.2 |
GO:1901990 |
regulation of cell cycle phase transition(GO:1901987) regulation of mitotic cell cycle phase transition(GO:1901990) |
| 0.1 |
0.2 |
GO:0051790 |
short-chain fatty acid biosynthetic process(GO:0051790) |
| 0.1 |
0.1 |
GO:0048875 |
surfactant homeostasis(GO:0043129) chemical homeostasis within a tissue(GO:0048875) |
| 0.1 |
0.3 |
GO:0007492 |
endoderm development(GO:0007492) |
| 0.1 |
0.3 |
GO:0007468 |
regulation of rhodopsin gene expression(GO:0007468) |
| 0.1 |
0.2 |
GO:0051823 |
regulation of synapse structural plasticity(GO:0051823) |
| 0.1 |
0.2 |
GO:0071918 |
urea transmembrane transport(GO:0071918) |
| 0.1 |
0.1 |
GO:0042097 |
interleukin-4 biosynthetic process(GO:0042097) regulation of interleukin-4 biosynthetic process(GO:0045402) positive regulation of interleukin-4 biosynthetic process(GO:0045404) |
| 0.1 |
0.2 |
GO:0007632 |
visual behavior(GO:0007632) |
| 0.1 |
0.5 |
GO:0042347 |
negative regulation of NF-kappaB import into nucleus(GO:0042347) |
| 0.1 |
1.3 |
GO:0006101 |
citrate metabolic process(GO:0006101) |
| 0.1 |
0.3 |
GO:0031122 |
cytoplasmic microtubule organization(GO:0031122) |
| 0.1 |
0.2 |
GO:0042119 |
granulocyte activation(GO:0036230) neutrophil activation(GO:0042119) |
| 0.1 |
0.1 |
GO:0002385 |
innate immune response in mucosa(GO:0002227) mucosal immune response(GO:0002385) |
| 0.1 |
0.1 |
GO:0040015 |
negative regulation of multicellular organism growth(GO:0040015) |
| 0.1 |
0.1 |
GO:0040020 |
regulation of meiotic nuclear division(GO:0040020) |
| 0.1 |
0.6 |
GO:0030032 |
lamellipodium assembly(GO:0030032) |
| 0.1 |
0.2 |
GO:0032464 |
positive regulation of protein oligomerization(GO:0032461) positive regulation of protein homooligomerization(GO:0032464) |
| 0.1 |
1.4 |
GO:0016079 |
synaptic vesicle exocytosis(GO:0016079) |
| 0.1 |
0.1 |
GO:0032922 |
circadian regulation of gene expression(GO:0032922) |
| 0.1 |
0.5 |
GO:0030854 |
positive regulation of granulocyte differentiation(GO:0030854) |
| 0.1 |
0.2 |
GO:0070059 |
intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress(GO:0070059) |
| 0.1 |
0.1 |
GO:0061005 |
cell differentiation involved in kidney development(GO:0061005) |
| 0.1 |
0.2 |
GO:0000012 |
single strand break repair(GO:0000012) |
| 0.1 |
1.0 |
GO:0005513 |
detection of calcium ion(GO:0005513) |
| 0.1 |
0.2 |
GO:0010172 |
embryonic body morphogenesis(GO:0010172) |
| 0.1 |
1.3 |
GO:0043631 |
RNA polyadenylation(GO:0043631) |
| 0.1 |
0.2 |
GO:0070254 |
mucus secretion(GO:0070254) |
| 0.1 |
0.1 |
GO:0075136 |
response to defenses of other organism involved in symbiotic interaction(GO:0052173) response to host defenses(GO:0052200) response to host(GO:0075136) |
| 0.1 |
0.6 |
GO:0045670 |
regulation of osteoclast differentiation(GO:0045670) |
| 0.1 |
0.1 |
GO:0045292 |
mRNA cis splicing, via spliceosome(GO:0045292) |
| 0.1 |
0.1 |
GO:0034287 |
detection of carbohydrate stimulus(GO:0009730) detection of hexose stimulus(GO:0009732) detection of monosaccharide stimulus(GO:0034287) detection of glucose(GO:0051594) |
| 0.1 |
0.1 |
GO:0007034 |
vacuolar transport(GO:0007034) |
| 0.1 |
0.3 |
GO:0018101 |
protein citrullination(GO:0018101) |
| 0.1 |
0.1 |
GO:0006817 |
phosphate ion transport(GO:0006817) |
| 0.1 |
0.1 |
GO:0043628 |
ncRNA 3'-end processing(GO:0043628) |
| 0.1 |
0.1 |
GO:0071542 |
dopaminergic neuron differentiation(GO:0071542) |
| 0.1 |
0.9 |
GO:0015701 |
bicarbonate transport(GO:0015701) |
| 0.1 |
0.3 |
GO:0006302 |
double-strand break repair(GO:0006302) |
| 0.1 |
0.2 |
GO:0098543 |
detection of bacterium(GO:0016045) detection of other organism(GO:0098543) |
| 0.1 |
0.1 |
GO:0016572 |
histone phosphorylation(GO:0016572) |
| 0.1 |
0.2 |
GO:0033211 |
adiponectin-activated signaling pathway(GO:0033211) |
| 0.1 |
0.5 |
GO:0006359 |
regulation of transcription from RNA polymerase III promoter(GO:0006359) |
| 0.1 |
0.3 |
GO:0006906 |
vesicle fusion(GO:0006906) |
| 0.1 |
0.7 |
GO:0032392 |
DNA geometric change(GO:0032392) |
| 0.1 |
0.5 |
GO:0051101 |
regulation of DNA binding(GO:0051101) |
| 0.1 |
0.1 |
GO:0021854 |
hypothalamus development(GO:0021854) |
| 0.1 |
0.2 |
GO:0006428 |
isoleucyl-tRNA aminoacylation(GO:0006428) |
| 0.1 |
0.2 |
GO:0006704 |
glucocorticoid biosynthetic process(GO:0006704) |
| 0.1 |
1.6 |
GO:0007188 |
adenylate cyclase-modulating G-protein coupled receptor signaling pathway(GO:0007188) |
| 0.1 |
0.9 |
GO:0016338 |
calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
| 0.1 |
0.2 |
GO:0070995 |
NADPH oxidation(GO:0070995) |
| 0.0 |
6.7 |
GO:0006813 |
potassium ion transport(GO:0006813) |
| 0.0 |
0.6 |
GO:0006577 |
amino-acid betaine metabolic process(GO:0006577) carnitine metabolic process(GO:0009437) |
| 0.0 |
0.1 |
GO:0031282 |
regulation of guanylate cyclase activity(GO:0031282) |
| 0.0 |
0.0 |
GO:0006304 |
DNA modification(GO:0006304) |
| 0.0 |
0.0 |
GO:0002507 |
tolerance induction(GO:0002507) |
| 0.0 |
0.1 |
GO:0019441 |
tryptophan catabolic process to kynurenine(GO:0019441) |
| 0.0 |
2.7 |
GO:0007608 |
sensory perception of smell(GO:0007608) |
| 0.0 |
0.2 |
GO:0042698 |
ovulation cycle(GO:0042698) |
| 0.0 |
0.0 |
GO:0009405 |
pathogenesis(GO:0009405) |
| 0.0 |
1.3 |
GO:0031638 |
zymogen activation(GO:0031638) |
| 0.0 |
0.4 |
GO:0021766 |
hippocampus development(GO:0021766) |
| 0.0 |
0.1 |
GO:0015864 |
pyrimidine nucleoside transport(GO:0015864) |
| 0.0 |
0.5 |
GO:0030514 |
negative regulation of BMP signaling pathway(GO:0030514) |
| 0.0 |
0.4 |
GO:0042354 |
fucose catabolic process(GO:0019317) L-fucose metabolic process(GO:0042354) L-fucose catabolic process(GO:0042355) |
| 0.0 |
0.4 |
GO:0006521 |
regulation of cellular amino acid metabolic process(GO:0006521) |
| 0.0 |
0.4 |
GO:0008088 |
axo-dendritic transport(GO:0008088) |
| 0.0 |
0.9 |
GO:0000288 |
nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:0000288) |
| 0.0 |
0.0 |
GO:0035137 |
hindlimb morphogenesis(GO:0035137) |
| 0.0 |
1.0 |
GO:0000910 |
cytokinesis(GO:0000910) |
| 0.0 |
0.1 |
GO:0003207 |
cardiac chamber formation(GO:0003207) cardiac ventricle formation(GO:0003211) |
| 0.0 |
0.2 |
GO:0046839 |
phospholipid dephosphorylation(GO:0046839) |
| 0.0 |
0.2 |
GO:0042461 |
photoreceptor cell development(GO:0042461) |
| 0.0 |
0.2 |
GO:0007215 |
glutamate receptor signaling pathway(GO:0007215) |
| 0.0 |
0.3 |
GO:1902603 |
carnitine shuttle(GO:0006853) carnitine transmembrane transport(GO:1902603) |
| 0.0 |
1.0 |
GO:0000245 |
spliceosomal complex assembly(GO:0000245) |
| 0.0 |
0.3 |
GO:0009953 |
dorsal/ventral pattern formation(GO:0009953) |
| 0.0 |
0.1 |
GO:0000216 |
obsolete M/G1 transition of mitotic cell cycle(GO:0000216) |
| 0.0 |
2.3 |
GO:0060333 |
interferon-gamma-mediated signaling pathway(GO:0060333) |
| 0.0 |
0.1 |
GO:0009301 |
snRNA transcription(GO:0009301) |
| 0.0 |
0.3 |
GO:0006220 |
pyrimidine nucleotide metabolic process(GO:0006220) |
| 0.0 |
0.1 |
GO:0070528 |
protein kinase C signaling(GO:0070528) |
| 0.0 |
0.2 |
GO:0046037 |
GMP metabolic process(GO:0046037) |
| 0.0 |
0.1 |
GO:0007603 |
phototransduction, visible light(GO:0007603) |
| 0.0 |
0.1 |
GO:0048625 |
myoblast fate commitment(GO:0048625) |
| 0.0 |
0.2 |
GO:0002430 |
complement receptor mediated signaling pathway(GO:0002430) |
| 0.0 |
0.1 |
GO:0044349 |
nucleotide-excision repair, DNA damage removal(GO:0000718) DNA excision(GO:0044349) |
| 0.0 |
0.3 |
GO:0015014 |
heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
| 0.0 |
0.9 |
GO:0043244 |
regulation of protein complex disassembly(GO:0043244) |
| 0.0 |
0.1 |
GO:0051932 |
synaptic transmission, GABAergic(GO:0051932) |
| 0.0 |
0.1 |
GO:0051124 |
synaptic growth at neuromuscular junction(GO:0051124) |
| 0.0 |
1.1 |
GO:0006308 |
DNA catabolic process(GO:0006308) |
| 0.0 |
0.0 |
GO:0034505 |
tooth mineralization(GO:0034505) |
| 0.0 |
0.2 |
GO:0021615 |
glossopharyngeal nerve development(GO:0021563) glossopharyngeal nerve morphogenesis(GO:0021615) |
| 0.0 |
0.0 |
GO:0002331 |
immature B cell differentiation(GO:0002327) pre-B cell differentiation(GO:0002329) pre-B cell allelic exclusion(GO:0002331) |
| 0.0 |
0.1 |
GO:0042560 |
10-formyltetrahydrofolate metabolic process(GO:0009256) 10-formyltetrahydrofolate catabolic process(GO:0009258) folic acid-containing compound catabolic process(GO:0009397) pteridine-containing compound catabolic process(GO:0042560) |
| 0.0 |
0.7 |
GO:0007187 |
G-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger(GO:0007187) |
| 0.0 |
0.1 |
GO:0015802 |
basic amino acid transport(GO:0015802) |
| 0.0 |
0.1 |
GO:0042226 |
interleukin-6 biosynthetic process(GO:0042226) |
| 0.0 |
0.1 |
GO:0048857 |
neural nucleus development(GO:0048857) |
| 0.0 |
0.1 |
GO:0043249 |
erythrocyte maturation(GO:0043249) |
| 0.0 |
0.6 |
GO:0006298 |
mismatch repair(GO:0006298) |
| 0.0 |
0.2 |
GO:0006600 |
creatine metabolic process(GO:0006600) |
| 0.0 |
0.2 |
GO:0042094 |
interleukin-2 biosynthetic process(GO:0042094) |
| 0.0 |
3.1 |
GO:0042254 |
ribosome biogenesis(GO:0042254) |
| 0.0 |
0.9 |
GO:0000084 |
mitotic S phase(GO:0000084) |
| 0.0 |
0.1 |
GO:0060012 |
synaptic transmission, glycinergic(GO:0060012) |
| 0.0 |
0.2 |
GO:0006772 |
thiamine metabolic process(GO:0006772) |
| 0.0 |
0.1 |
GO:0032486 |
Rap protein signal transduction(GO:0032486) |
| 0.0 |
0.2 |
GO:0051966 |
regulation of synaptic transmission, glutamatergic(GO:0051966) |
| 0.0 |
0.1 |
GO:0097061 |
dendritic spine morphogenesis(GO:0060997) regulation of dendritic spine morphogenesis(GO:0061001) dendritic spine organization(GO:0097061) |
| 0.0 |
0.1 |
GO:0001953 |
negative regulation of cell-matrix adhesion(GO:0001953) |
| 0.0 |
0.1 |
GO:0007060 |
male meiosis chromosome segregation(GO:0007060) |
| 0.0 |
0.1 |
GO:0048147 |
negative regulation of fibroblast proliferation(GO:0048147) |
| 0.0 |
0.1 |
GO:1902749 |
regulation of G2/M transition of mitotic cell cycle(GO:0010389) regulation of cell cycle G2/M phase transition(GO:1902749) |
| 0.0 |
0.0 |
GO:0050857 |
positive regulation of antigen receptor-mediated signaling pathway(GO:0050857) positive regulation of T cell receptor signaling pathway(GO:0050862) |
| 0.0 |
0.0 |
GO:0034625 |
fatty acid elongation, monounsaturated fatty acid(GO:0034625) |
| 0.0 |
0.0 |
GO:0006166 |
purine ribonucleoside salvage(GO:0006166) |
| 0.0 |
0.6 |
GO:0070830 |
bicellular tight junction assembly(GO:0070830) |
| 0.0 |
0.4 |
GO:0007623 |
circadian rhythm(GO:0007623) |
| 0.0 |
1.6 |
GO:0007218 |
neuropeptide signaling pathway(GO:0007218) |
| 0.0 |
0.1 |
GO:0007286 |
spermatid development(GO:0007286) |
| 0.0 |
0.2 |
GO:0007171 |
activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
| 0.0 |
0.0 |
GO:0097531 |
mast cell chemotaxis(GO:0002551) regulation of mast cell chemotaxis(GO:0060753) positive regulation of mast cell chemotaxis(GO:0060754) mast cell migration(GO:0097531) |
| 0.0 |
0.4 |
GO:0007602 |
phototransduction(GO:0007602) |
| 0.0 |
0.1 |
GO:0007549 |
dosage compensation(GO:0007549) |
| 0.0 |
0.1 |
GO:0051925 |
obsolete regulation of calcium ion transport via voltage-gated calcium channel activity(GO:0051925) |
| 0.0 |
0.3 |
GO:0007043 |
cell-cell junction assembly(GO:0007043) |
| 0.0 |
0.0 |
GO:0046884 |
follicle-stimulating hormone secretion(GO:0046884) |
| 0.0 |
0.0 |
GO:0045885 |
obsolete positive regulation of survival gene product expression(GO:0045885) |
| 0.0 |
0.0 |
GO:0060011 |
Sertoli cell proliferation(GO:0060011) |
| 0.0 |
0.2 |
GO:0032272 |
negative regulation of protein polymerization(GO:0032272) |
| 0.0 |
0.1 |
GO:0010761 |
fibroblast migration(GO:0010761) |
| 0.0 |
0.2 |
GO:0006465 |
signal peptide processing(GO:0006465) |
| 0.0 |
0.6 |
GO:0071357 |
response to type I interferon(GO:0034340) type I interferon signaling pathway(GO:0060337) cellular response to type I interferon(GO:0071357) |
| 0.0 |
0.1 |
GO:0010886 |
cholesterol storage(GO:0010878) regulation of cholesterol storage(GO:0010885) positive regulation of cholesterol storage(GO:0010886) |
| 0.0 |
0.0 |
GO:0048535 |
lymph node development(GO:0048535) |
| 0.0 |
0.1 |
GO:0032703 |
negative regulation of interleukin-2 production(GO:0032703) |
| 0.0 |
0.1 |
GO:0007031 |
peroxisome organization(GO:0007031) |
| 0.0 |
0.1 |
GO:0050689 |
negative regulation of defense response to virus by host(GO:0050689) |
| 0.0 |
0.0 |
GO:0070857 |
regulation of bile acid biosynthetic process(GO:0070857) regulation of bile acid metabolic process(GO:1904251) |
| 0.0 |
0.7 |
GO:0002756 |
MyD88-independent toll-like receptor signaling pathway(GO:0002756) |
| 0.0 |
0.0 |
GO:0046485 |
ether lipid metabolic process(GO:0046485) |
| 0.0 |
0.0 |
GO:0006084 |
acetyl-CoA metabolic process(GO:0006084) |
| 0.0 |
0.1 |
GO:0001502 |
cartilage condensation(GO:0001502) cell aggregation(GO:0098743) |
| 0.0 |
0.0 |
GO:0006857 |
oligopeptide transport(GO:0006857) |
| 0.0 |
0.2 |
GO:0045047 |
protein targeting to ER(GO:0045047) establishment of protein localization to endoplasmic reticulum(GO:0072599) |
| 0.0 |
0.0 |
GO:0001955 |
blood vessel maturation(GO:0001955) |
| 0.0 |
0.1 |
GO:1901072 |
amino sugar catabolic process(GO:0046348) glucosamine-containing compound catabolic process(GO:1901072) |
| 0.0 |
0.3 |
GO:0007158 |
neuron cell-cell adhesion(GO:0007158) |
| 0.0 |
0.1 |
GO:0042551 |
neuron maturation(GO:0042551) |
| 0.0 |
0.1 |
GO:0022406 |
membrane docking(GO:0022406) |
| 0.0 |
0.2 |
GO:0032436 |
positive regulation of proteasomal ubiquitin-dependent protein catabolic process(GO:0032436) positive regulation of proteasomal protein catabolic process(GO:1901800) |
| 0.0 |
0.2 |
GO:0046068 |
cGMP metabolic process(GO:0046068) |
| 0.0 |
0.0 |
GO:0070816 |
phosphorylation of RNA polymerase II C-terminal domain(GO:0070816) |
| 0.0 |
0.2 |
GO:0006289 |
nucleotide-excision repair(GO:0006289) |
| 0.0 |
0.0 |
GO:0006655 |
phosphatidylglycerol biosynthetic process(GO:0006655) cardiolipin metabolic process(GO:0032048) cardiolipin biosynthetic process(GO:0032049) phosphatidylglycerol metabolic process(GO:0046471) |
| 0.0 |
0.1 |
GO:0002066 |
columnar/cuboidal epithelial cell development(GO:0002066) |
| 0.0 |
0.1 |
GO:0018026 |
peptidyl-lysine monomethylation(GO:0018026) |
| 0.0 |
0.2 |
GO:0009312 |
oligosaccharide biosynthetic process(GO:0009312) |
| 0.0 |
0.0 |
GO:0001919 |
regulation of receptor recycling(GO:0001919) |
| 0.0 |
0.0 |
GO:0021872 |
forebrain generation of neurons(GO:0021872) |
